KR20180117307A - Composition for improving of shining effect - Google Patents

Composition for improving of shining effect Download PDF

Info

Publication number
KR20180117307A
KR20180117307A KR1020170050248A KR20170050248A KR20180117307A KR 20180117307 A KR20180117307 A KR 20180117307A KR 1020170050248 A KR1020170050248 A KR 1020170050248A KR 20170050248 A KR20170050248 A KR 20170050248A KR 20180117307 A KR20180117307 A KR 20180117307A
Authority
KR
South Korea
Prior art keywords
hexafluorophosphate
dimethylamino
benzotriazol
phosphonium
methylene
Prior art date
Application number
KR1020170050248A
Other languages
Korean (ko)
Other versions
KR102349949B1 (en
Inventor
손성길
유지희
김동완
최원경
이정래
이상민
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020170050248A priority Critical patent/KR102349949B1/en
Publication of KR20180117307A publication Critical patent/KR20180117307A/en
Application granted granted Critical
Publication of KR102349949B1 publication Critical patent/KR102349949B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

According to the present invention, a composition for increasing gloss effects contains a functional component having at least one amine or carboxyl-reactive group capable of covalently bonding with proteins on hair, scalp, skin, nail, leather, or fiber. By forming a covalent bond between the protein and the functional component, it is possible to increase semi-permanent gloss effects.

Description

윤기 강화용 조성물 {Composition for improving of shining effect}{Composition for improving shining effect}

본 발명은 모발, 피부, 손발톱, 가죽 또는 섬유의 윤기 강화용 조성물에 관한 것이다.The present invention relates to a composition for enhancing the shine of hair, skin, nails, leather or fibers.

피부는 신체의 표면을 덮고 있는 조직으로, 표피, 진피 및 피하 지방층으로 이루어지며, 피부 부속기로는 한선, 피지선, 모발 및 손, 발톱 등이 있다. 이와 같은 피부의 최외곽을 구성하는 표피는 외배엽에서 유래하며 크게 말피기층이라 불리는 살아있는 세포로 구성된 안쪽의 부분과 무핵이며 편평하고 건조한 죽은 세포들로 이루어진 각질층인 외곽부분으로 이루어져 있다. 두께는 얼굴 부분이 0.03mm 내지 1mm, 손, 발바닥이 0.16mm 내지 0.8mm이고, 가장 얇은 눈꺼풀은 0.1mm 정도이다. 표피는 주로 중층편평각화상피로서, 주로 각질형성 세포로 이루어져 있으며 그 외에 멜라닌 세포, 랑게르한스 세포 및 머켈 세포가 존재한다.The skin is a tissue covering the surface of the body, consisting of epidermis, dermis and subcutaneous fat layer, and skin adherens include Hansoon, sebaceous gland, hair and hands and claws. The epidermis, which constitutes the outermost part of the skin, is composed of an inner part derived from ectoderm and composed of living cells called largely the epithelial layer, and an outer part composed of a stratum corneum composed of flattened, dry dead cells. The thickness of the face portion is 0.03 mm to 1 mm, the hands and soles are 0.16 mm to 0.8 mm, and the thinnest eyelid is 0.1 mm. The epidermis is mainly a middle layer flattened keratinized epithelium, mainly composed of keratinocytes, and melanocytes, Langerhans cells and Merkel cells.

각질형성 세포는 표피의 주요 구성성분으로 표피의 바깥 부분에서부터 각질층, 과립층, 유극층 및 기저층의 4개 층으로 이루어져 있으며, 손, 발바닥 부위에는 각질층과 과립층 사이에 투명층이 존재한다. The keratinocyte is a major constituent of the epidermis and consists of four strata from the outer part of the epidermis to the stratum corneum, the granular layer, the superficial layer and the basal layer. There is a transparent layer between the stratum corneum and the granular layer at the hands and soles.

표피에는 매일 수백만 개의 새로운 세포들이 형성되고 있으며, 이들은 한 장소에 머무르지 않고 표피의 가장 바깥쪽으로 계속해서 밀려나오기 시작한다. 이때 밀려 올라오는 동안에 이 세포들은 점점 딱딱한 각질로 바뀌어 가게 된다. 표피의 세포는 기저층에서 처음 만들어지며 점차 표면으로 밀려나오면서 모양과 기능 또한 변하게 된다. Millions of new cells are formed every day in the epidermis, and they do not stay in one place but continue to push outward to the outermost of the epidermis. During this time, these cells become increasingly harder. Cells of the epidermis are first made in the basal layer and gradually come out to the surface, changing shape and function.

표피는 각화됨에 따라 기저층, 유극층, 과립층, 각질층으로 점차 모양이 변하게 되며, 이들 세포들은 모두 각질을 형성하는 과정에서 만들어진 세포이므로 각질형성 세포라 부른다.As the epidermis becomes keratinized, the shape gradually changes to the basal layer, the superficial layer, the granular layer, and the stratum corneum. These cells are called keratinized cells because they are cells formed during the process of forming keratin.

각질형성세포에서의 분화과정은 1) 기저세포의 분열 과정, 2) 유극 세포에서의 합성 및 정비과정, 3) 과립세포에서의 자기 분해 과정, 4) 각질세포에서의 재구축 과정의 4단계에 걸쳐서 일어나며, 분화의 마지막 단계로 각질층이 형성된다. 이와 같은 과정을 각화(keratinization) 과정이라 한다. The differentiation process in keratinocytes is divided into four stages: 1) division of basal cells, 2) synthesis and maintenance of goblet cells, 3) autolysis of granule cells, and 4) reconstruction of keratinocytes , And the stratum corneum is formed as the last stage of differentiation. This process is called keratinization process.

각질형성 세포의 수명은 약 28일이며, 부위에 따라 조금씩 다르나 매일 수백만 개씩 떨어져 나가고 아래의 층으로부터 수백만 개의 새로운 세포가 생성되어 올라오게 된다. 인체의 피부 표면에서는 노화된 각질세포가 계속 떨어져 나가고 있으며, 노화된 피부에서는 각질층이 떨어지는데 더 많은 시간이 걸리므로 각질층이 두꺼워지게 된다. 따라서 각질형성 세포의 기능 저하는 죽은 세포를 더욱 늘어나게 하고, 잔주름과 피부 거칠어짐의 원인이 된다.The keratinocyte has a life span of about 28 days, which varies a little depending on the site, but millions of cells are removed every day and millions of new cells are generated from the lower layers. On the skin surface of the human body, the aging keratinocytes continue to fall off, and in the aged skin, it takes more time for the keratin layer to fall, and the stratum corneum becomes thicker. Therefore, degradation of keratinocyte cells leads to further increase of dead cells, causing fine lines and rough skin.

각질층은 각질형성 세포 중 가장 바깥쪽의 단단하고 건조한 얇은 껍질인 각질을 형성하고 있는 부분으로 20 내지 25개의 층으로 되어 있다. 각질층이란 단백질이 딱딱하게 변한 케라틴(keratin)으로 이루어져 있다는 뜻에서 붙여진 이름이다. 각질층의 모양은 피부의 표면에 가까울수록 납작하고 길쭉한 모양을 하게 된다. 주성분으로는 케라틴 단백질(58%), 지질(11%), 천연보습인자(natural moisturizing factor: NMF, 38%)를 함유하고 있다. 두께는 신체의 부위에 따라 다르며, 손바닥이나 발바닥과 같은 부위는 각질층이 매우 두꺼워 일상생활에서 받는 물리적 충격이나 마찰 또는 외상에도 잘 견딜 수 있도록 한다. 각질층은 비록 핵이 없는 죽은 세포와 케라틴이라는 단백질로 구성되어 있으나, 피부의 보호 기능에서 가장 중요한 위치를 차지하고 있다. 이 각질층은 외부에서 세균이나 외부의 독성물질이 함부로 몸 속으로 침입하지 못하도록 막아주고, 또 몸의 내부에서 수분이 빠져나가지 못하도록 하는 중요한 방어막 구실을 한다. 이러한 피부 각질의 주요 구성 성분인 케라틴 단백질(58%)은 글리신, 알라닌, 발린, 류신, 이소류신, 트레오닌, 세린, 시스테인, 시스틴, 메티오닌, 아스파르트산, 아스파라긴, 글루탐산, 디요드티로신, 리신, 아르기닌, 히스티딘, 페닐알라닌, 티로신, 트립토판, 프롤린, 옥시프롤린 등의 아미노산으로 구성되며, 특히 피부 각질을 구성하는 케라틴은 약 6.4 내지 8.1%의 아스파라긴산, 약 9.1 내지 15.4%의 글루타민산 그리고 약 3.1 내지 6.9%의 라이신을 포함한다.The stratum corneum is a part of the outermost keratinocyte that forms a hard, dry thin skin, keratin, 20 to 25 layers. The stratum corneum is a name given to the fact that the protein is made up of keratin, which is a hardened one. The shape of the stratum corneum becomes flat and elongated as it is closer to the surface of the skin. The main ingredients are keratin protein (58%), lipid (11%) and natural moisturizing factor (NMF, 38%). The thickness varies depending on the area of the body, and the areas such as the palms and soles are very thick, allowing them to withstand the physical impact, friction or trauma they experience in daily life. The stratum corneum, although composed of dead cells without nucleus and a protein called keratin, is the most important position in the protection of the skin. This stratum corneum protects bacteria and external toxins from entering the body from the outside, and serves as an important barrier to prevent moisture from escaping from inside the body. The keratin protein (58%), which is a major constituent of the skin keratin, is composed of glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, cystine, methionine, aspartic acid, asparagine, glutamic acid, Wherein the keratin constituting the skin keratin is composed of about 6.4 to 8.1% of aspartic acid, about 9.1 to 15.4% of glutamic acid, and about 3.1 to 6.9% of lysine < RTI ID = 0.0 & .

일반적으로 모발은 포유류의 피부 부속기관으로서 발생학적으로 표피의 상피가 함입되어 형성된 각질화 된 구조로, 땀샘, 피지샘과 함께 피부의 부속 기관에 해당된다. 모발은 머리카락, 솜털, 수염, 겨드랑이털, 음모 등 인체 외부를 덮고 있는 털을 모두 포함하며 경우에 따라서는 두피의 머리카락만을 의미 하기도 한다. In general, hair is a mammalian skin attachment organ, and it is a keratinized structure formed by embryonic epidermal epithelium implanted into the skin, accompanied by sweat glands and sebaceous glands. Hair includes hair, fluffy hair, beard, armpit hair, and pubic hair covering the outside of the body, and in some cases, it refers to only the hair of the scalp.

모발은 피부 각질층의 주성분과 같은 케라틴 단백질로 구성되어 있고, 케라틴은 그 유래에 따라 크게 2가지로 구분된다. 피부 각질층을 구성하는 케라틴을 연성 케라틴이라 하고, 모발과 손톱을 구성하는 케라틴을 경성 케라틴이라 한다. 이것은 아미노산 중 하나인 시스테인의 함량에 따른 차이로, 경성 케라틴은 시스테인 함량이 높고 연성 케라틴은 그 함량이 낮다. 따라서, 경성 케라틴은 외부 자극이나 화학물질의 침해에 대한 저항력이 강하다. Hair is composed of keratin proteins which are the main components of the skin stratum corneum. Keratin is divided into two types according to its origins. The keratin constituting the skin stratum corneum is called soft keratin, and the keratin constituting hair and nail is called hard keratin. This is due to differences in the content of cysteine, which is one of the amino acids. The hard keratin has a high cysteine content and the soft keratin has a low content. Thus, hard keratin is resistant to external stimuli or chemical attack.

모발 섬유는 굵기가 약 50 내지 100㎛이며, 모소피로 불리는 큐티클(cuticle)과 모피질로 불리는 콜텍스(cortex)로 구성되고, 때로 가운데 부분에 모수질이라 불려지는 메듈라(medulla)를 가지기도 한다. 이들 모든 세포는 죽은 세포로 되어있고 대부분이 케라틴 단백질로 채워져 있다. Hair fibers have a thickness of about 50 to 100 μm and consist of a cuticle called follicle and a cortex called follicle and sometimes have a medulla called medulla in the middle . All these cells are dead cells and most of them are filled with keratin protein.

사람의 모발은 약 65 내지 95%가 케라틴 단백질로 구성되어 있고, 물과 지질(결합 및 비결합 형태), 안료, 미량원소를 포함하고 있다. 단백질은 약 20 내지 50개의 아미노산 혼합물들이 긴 사슬을 형성하여 만들어지며, 각 사슬은 나선이나 코일 형태로 감겨져 있다. Human hair consists of about 60 to 95% of keratin proteins and contains water and lipids (bound and unconjugated forms), pigments and trace elements. Proteins are made by forming long chains of about 20 to 50 amino acid mixtures, and each chain is coiled in the form of helix or coil.

사람 모발을 구성하는 수많은 아미노산 조성 중에서 시스틴은 가장 중요한 아미노산 중 하나이다. 시스틴은 서로 다른 아미노산 사슬에 존재하는 두 개의 시스테인(치올)에 의해서 구성되며, 서로 근접된 상태로 두 황(sulfur) 원자간에 결합을 형성한 매우 강한 결합으로 알려져 있는 디설파이드 결합(disulfide bond)을 형성하고 있다. 디설파이드 결합 이외에도 모발은 매우 풍부한 펩타이드 결합(peptide bond)을 포함하고 있다. 또한 많은 CO-와 NH-기가 존재함에 의해서 이웃한 사슬 분자 그룹들 사이에 수소 결합을 일으키게 된다. 하지만 인간 모발의 세포 구조에 있어서 매우 독특한 부분인 높은 시스틴 함량에 의해서 모발의 물리학적 특성이 나타나게 된다. 모발의 색상과 관련 있는 부분인 안료는 멜라닌(melanin)이며 이는 사람 모발의 콜텍스 부분에 그래뉼(granule) 형태로 주로 존재하고 있다. Of the many amino acid compositions that make up human hair, cystine is one of the most important amino acids. Cystine is formed by two cysteines (chiols) present in different amino acid chains and forms a disulfide bond known as a very strong bond that forms a bond between two sulfur atoms in close proximity to each other . In addition to disulfide bonds, hair contains a very abundant peptide bond. In addition, the presence of many CO- and NH- groups leads to hydrogen bonding between neighboring chain molecule groups. However, the high cystine content, a very unique part of the cellular structure of human hair, reveals the physical properties of the hair. The pigment that is related to the color of the hair is melanin, which is mainly present in granule form in the colctex part of human hair.

모발의 대부분은 단백질이며 나머지 성분은 멜라닌 색소, 지질, 미량원소, 수분 등이다. 모발의 아미노산 조성 대부분을 구성하고 있는 단백질은 시스테인을 많이 함유하고 있는 케라틴 단백질이다. 모발 케라틴은 약 18종의 아미노산으로 되어 있으며, 그 조성에 있어서 사람의 표피와 비교하여 시스테인의 함유량이 많다. 또한 염기성 아미노산인 히스티딘, 라이신, 알기닌의 비율은 1:3:10인데 이는 모발 케라틴만의 특유한 비율이다. 피부 콜라겐은 시스테인이 없고 대신에 글라이신, 프로린, 및 알라닌 함량이 높다. 모발의 색을 결정하는 멜라닌 색소는 모발에 약 3% 이하로 함유되어 있다. Most of the hair is protein, and the rest are melanin pigment, lipid, trace element, moisture. The protein that constitutes most of the amino acid composition of hair is a keratin protein which contains a lot of cysteine. Hair keratin is composed of about 18 kinds of amino acids, and its composition has a large content of cysteine in comparison with human epidermis. The ratio of basic amino acids histidine, lysine and arginine is 1: 3: 10, which is a unique ratio of hair keratin. Skin collagen does not have cysteine but instead has high glycine, proline, and alanine content. The melanin pigment that determines the color of the hair is contained in the hair by about 3% or less.

단백질과 멜라닌 색소 이외에도 모발 중에는 구리, 아연, 철, 망간, 칼슘, 마그네슘 같은 미네랄과 미량원소들을 포함하고 있으며, 이외에도 인, 규소, 등 무기성분이 존재하는 것으로 알려져 있다. In addition to protein and melanin pigments, hair contains minerals and trace elements such as copper, zinc, iron, manganese, calcium, and magnesium. In addition, inorganic elements such as phosphorus and silicon are known to exist.

모발에 존재하는 결합은 단백질 내부의 아미노산들 사이의 펩타이드 결합(Peptide Bond) 이외에도 각각의 단백질 분자들 사이에는 분자 간의 힘이나 결합력이 존재하고, 이 결합에 의해 모발은 그 성상 및 형태를 유지한다. 결합의 종류는 크게 가교결합인 시스틴 결합과 펩타이드 결합, 그리고 비가교 결합인 염 결합, 수소결합, 소수성 상호작용 등이 있다. 그 중 시스틴 결합(Cystine Bond; Disulfide Bond; -CH2-S-S-CH2-)은 황(S)을 함유하는 단백질에서 특이하게 나타나는 것으로, 다른 섬유에서는 보이지 않는 측쇄 결합이며 케라틴에서 특징적으로 나타나는 결합이다. 이 시스틴 결합으로 케라틴은 강한 물리 화학적 특성을 나타낸다. In addition to the peptide bonds between the amino acids inside the protein, the bonds existing in the hair also have intermolecular forces and binding forces between the respective protein molecules, and the hair maintains its properties and shape by this binding. The types of bonds are largely cysteine bonds, peptide bonds, and non-crosslinked salt bonds, hydrogen bonds, and hydrophobic interactions. Among them, cystine bond (Disulfide Bond; -CH 2 -SS-CH 2 -) is a side chain bond that is unseen in other fibers and is characteristic of keratin. to be. With this cystine bond, keratin shows strong physico-chemical properties.

이러한 모발의 주요 구성 성분인 케라틴 단백질(58%)은 글리신, 알라닌, 발린, 류신, 이소류신, 트레오닌, 세린, 시스테인, 시스틴, 메티오닌, 아스파르트산, 아스파라긴, 글루탐산, 디요드티로신, 리신, 아르기닌, 히스티딘, 페닐알라닌, 티로신, 트립토판, 프롤린, 옥시프롤린 등의 아미노산으로 구성되며, 특히 모발을 구성하는 케라틴은 약 3.9 내지 7.7%의 아스파라긴산, 약 13.6 내지 14.2%의 글루타민산 그리고 약 1.9 내지 3.1%의 라이신을 포함한다.The keratin protein (58%), a major constituent of such hair, is a glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, cystine, methionine, aspartic acid, asparagine, glutamic acid, diiodothyrosine, lysine, arginine, histidine Wherein the keratin constituting the hair contains about 3.9 to 7.7% of aspartic acid, about 13.6 to 14.2% of glutamic acid and about 1.9 to 3.1% of lysine. The hair follicle according to claim 1, wherein the hair follicle comprises an amino acid such as phenylalanine, tyrosine, tryptophan, proline or oxyproline. do.

섬유는 일반적으로 크게 천연 섬유와 인조 섬유로 나눠질 수 있는데, 천연 섬유 중 동물체로부터 얻은 섬유를 동물성 섬유라고 하며, 화학적 성분이 단백질이므로 단백질계 섬유라고도 한다. 단백질계 섬유는 동물의 털에서 얻은 섬유와 누에고치로부터 얻은 섬유가 있으며, 동물의 털에서 얻은 섬유는 면양의 털로부터 얻은 모섬유와 산양, 낙타, 토끼, 말, 소, 기타 동물들로부터 얻는 헤어 섬유로 나눌 수 있다.Fibers are generally divided broadly into natural fibers and man-made fibers. Fibers obtained from animals in natural fibers are called animal fibers, and are also called protein fibers since they are proteins. Protein-based fibers are fibers obtained from animal hair and fibers obtained from cocoon, and fibers obtained from animal hair are obtained from flax obtained from hair of sheep, hair fibers obtained from goats, camels, rabbits, horses, cows and other animals .

이러한 단백질계 섬유는 모발과 동일하게 글리신, 알라닌, 발린, 류신, 이소류신, 트레오닌, 세린, 시스테인, 시스틴, 메티오닌, 아스파르트산, 아스파라긴, 글루탐산, 디요드티로신, 리신, 아르기닌, 히스티딘, 페닐알라닌, 티로신, 트립토판, 프롤린, 옥시프롤린 등의 아미노산으로 구성되며, 이러한 단백질계 섬유 중에서 가장 일반적으로 널리 사용되는 양모(울)는 아미노산의 조성 또한 모발과 유사한 조성을 갖는 것으로 알려져 있다. Such protein-based fibers can be used in the same manner as hair, such as glycine, alanine, valine, leucine, isoleucine, threonine, serine, cystine, cystine, methionine, aspartic acid, asparagine, glutamic acid, diiodothyrosine, lysine, arginine, histidine, phenylalanine, Tryptophan, proline, and oxyproline. Of these protein fibers, wool (wool), which is most commonly used, is known to have a composition of amino acid similar to that of hair.

이들 단백질계 섬유 및 모발, 피부, 손발톱, 가죽은 물 또는 중성 용매와 같은 온화한 조건에서는 매우 강한 단백질의 일종이지만, 일상생활에서 일어나는 빗질, 드라이어의 열, 염색, 퍼머, 일상생활에서의 물리적인 마찰, 세탁, 일광, 다림질의 열, 오염의 흡착, 자외선에의 노출, 고온 및 저온에의 노출, 해수, 풀장의 석회분 등 물리/화학적 처리 및 환경적 스트레스에 의해 쉽게 손상될 수 있다. 이에 따라 손상된 모발, 피부, 손발톱, 섬유 가죽은 내외부의 단백질이 용출되어 다공성화가 진행되고 거칠어지면서 부드러움 및 탄력이 떨어질 수 있고 마찰력 증가로 인해 손질이 어려워지며, 윤기가 떨어지고 색상이 탁해지는 등의 문제가 발생할 수 있다.These protein-based fibers and hair, skin, nails, and leather are a very strong protein in mild conditions such as water or neutral solvents, but they can be caused by combing in daily life, heat of hair, dyeing, permanent, It can be easily damaged by physical / chemical treatments such as washing, sunshine, ironing heat, adsorption of pollution, exposure to ultraviolet rays, exposure to high and low temperatures, seawater, limestone in the pool, and environmental stress. As a result, damaged hair, skin, nails, and fiber leathers can be softened due to elution of inner and outer proteins, becoming rough and porous, and softness and elasticity may be deteriorated, frictional force may become difficult to be cleaned, shine and color become cloudy May occur.

따라서 모발, 피부, 섬유, 가죽 등의 기질 표면 특성을 개선하여 아름답고 건강한 모습을 유지하기 위해 처리제를 사용하게 된다. 특히 윤기, 부드러움 및 매끄러움은 개선하고자 하는 중요한 대표적인 표면 특성이다.Therefore, the treatment agent is used to improve the surface properties of the hair such as hair, skin, fiber and leather to maintain a beautiful and healthy appearance. In particular, gloss, softness and smoothness are important representative surface properties to be improved.

윤기를 부여하기 위한 처리제의 대표 예시로, 모발에 있어서 샴푸, 린스, 트리트먼트, 왁스, 스프레이, 무스, 헤어 로션, 에센스, 헤어 크림, 팩, 마스크, 시트 등의 모발에 사용할 수 있는 화장품 제제들이 있으며, 피부에 있어서, 스킨, 로션, 에센스, 세럼, 크림, 젤, 파운데이션, 파우더, 메이크업베이스, 포인트 메이크업, 마스크, 패치 등의 피부에 사용할 수 있는 화장품 제제들이 있으며, 섬유에 있어서도, 섬유유연제, 섬유 염색제, 세탁세제, 트리트먼트제, 전후처리제, 세탁보조제, 부분오염 제거제, 스프레이 등의 섬유에 사용할 수 있는 섬유 케어 제제를 들 수 있다. 손발톱 처리제에 있어서도 광택제, 영양제, 강화제 등의 손, 발톱에 사용할 수 있는 제제를 들 수 있다. 가죽 제품에 있어서도 크림, 로션, 에센스, 세럼, 젤, 왁스, 스프레이, 세정제, 크리너, 부분 오염제거제, 연고타입, 광택제, 스트립, 시트 등 가죽 처리용의 제제를 들 수 있다. As a representative example of the treating agent for imparting luster, cosmetic preparations which can be used for hair such as shampoo, rinse, treatment, wax, spray, mousse, hair lotion, essence, hair cream, pack, There are cosmetic preparations which can be used on the skin such as skin, lotion, essence, serum, cream, gel, foundation, powder, makeup base, point makeup, mask, patch, A fiber care preparation that can be used for fibers such as a fiber dye, a laundry detergent, a treatment agent, a post-treatment agent, a laundry aid agent, a partial decontamination agent, and a spray. Also in the nail treatment agent, there can be mentioned a preparation which can be used for the hands and nails such as polishes, nutrients, and strengthening agents. Also in leather products, formulations for treating leather such as creams, lotions, essences, serums, gels, waxes, sprays, cleaners, cleaners, partial decontamination agents, ointment type, polishes, strips and sheets can be mentioned.

또한, 일반적으로 화장료라 함은 '신체를 청결히 하고, 미화하고, 매력을 증가시키고, 용모를 변화시키고, 또는 피부나 모발을 건강하게 유지하기 위하여 신체에 도포, 산포, 기타 이들에 유사한 방법으로 사용하는 것을 목적으로 한 것으로서, 인체에 대한 작용이 경미한 것을 말한다'라고 정의되어 있다. 이와 같은 화장료는 피부, 모발, 손톱 및 발톱 등과 같은 인체의 다양한 부위를 건강하고 아름답게 유지하기 위한 다양한 기능들을 포함하고 있으며, 그 중 윤기, 광택은 화장료의 주요 기능 중 하나라고 볼 수 있다.In general, cosmetics are also referred to as "cosmetics", which means "to clean, groom, charm, change appearance, or to apply healthy skin or hair to the body by applying, dispersing, And that the action on the human body is slight ". Such cosmetics include various functions for maintaining various parts of the human body such as skin, hair, nails and claws in a healthy and beautiful manner. Among them, glossiness and gloss are one of the main functions of cosmetics.

이러한 윤기용 화장료를 구성하는 일반적인 원료로는 유지, 왁스, 탄화수소, 고급지방산, 고급알콜, 에스텔유, 실리콘유 등과 같은 유성원료, 음이온, 양이온, 양쪽성, 비이온계 계면활성제, 보습제, 점증제 및 피막형성제로 사용되는 고분자화합물, 자외선흡수 및 차단제, 산화방지제, 금속이온봉쇄제, 염료 및 안료를 포함한 색재, 향료, 방부제 등을 포함하고 있다.Common raw materials constituting such a lubricating cosmetic composition include oily materials such as oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, ester oils and silicone oils, anions, cationic, amphoteric and nonionic surfactants, moisturizers, Antioxidants, metal ion sequestrants, coloring materials including dyes and pigments, fragrances, preservatives, and the like.

이 외에 또한, 특별한 성능을 제공하기 위한 성분으로 유지 및 천연 또는 합성 지방산, 지방 알코올, 알코올, 알킬글리세릴에테르, 에스테르, 탄화수소, 실리콘, 불소 화합물, 다가알콜, 당류, 천연 또는 합성 고분자, 왁스, 비타민류, 호르몬류, 아미노산, 펩타이드, 단백질, 동식물 추출물, 광물 추출물 및 이들의 유도체 등을 포함할 수 있다. In addition to the above, it is also possible to use as a component for providing a special performance, a preservative and a natural or synthetic fatty acid, a fatty alcohol, an alcohol, an alkyl glyceryl ether, an ester, a hydrocarbon, a silicone, a fluorine compound, a polyhydric alcohol, Vitamins, hormones, amino acids, peptides, proteins, plant and animal extracts, mineral extracts, derivatives thereof and the like.

그러나 이러한 조성물에 포함된 기능성 성분은 대부분 단순 흡착에 의해 효과를 부여하게 된다. 조성물 처리 후 일상생활에서 일어나는 다양한 외부 환경에 의해 윤기가 지속적으로 감소하게 되며, 세정 후에는 기능성 성분의 소실로 효과가 사라지게 되는 단점이 있다.However, most of the functional components contained in such a composition are imparted by simple adsorption. There is a disadvantage in that the gloss is continuously reduced due to various external environments occurring in everyday life after the composition treatment and the effect of disappearance of the functional ingredient is lost after cleaning.

예를 들어 특허문헌 1에서는 고함량의 오일 및 폴리올을 함유하면서 동시에 계면활성제를 함유하여 모발에 부드러움과 윤기를 제공하는 모발 세정용 조성물을 개시하고 있고, 특허문헌 2에서는 동백 추출물을 포함함으로써 모발에 윤기를 부여하는 화장료 조성물을 개시하고 있지만, 상기 2가지 조성물 윤기를 부여하는 주요 성분인 오일 또는 동백 추출물이 모발에 단순히 친소수성 결합(hydrophobic bond) 또는 단순 흡착함으로써 세정에 의해 쉽게 씻겨나가고 효과의 지속성이 떨어지는 문제가 있다.For example, Patent Document 1 discloses a hair cleansing composition which contains a high amount of oil and polyol and simultaneously contains a surfactant to provide softness and luster to the hair. Patent Document 2 discloses a hair cleansing composition containing a camellia extract, However, the oil or camellia extract, which is the main ingredient for imparting the two composition glosses, is easily washed away by washing with a simple hydrophobic bond or simple adsorption to the hair, There is a falling problem.

한국 공개특허 제2014-0141303호Korea Patent Publication No. 2014-0141303 한국 공개특허 제2013-0122070호Korea Patent Publication No. 2013-0122070

본 발명의 목적은 모발, 두피, 피부, 손발톱, 가죽 또는 섬유에 윤기를 부여할 수 있는 윤기 강화용 조성물을 제공하는데 있다.It is an object of the present invention to provide a composition for glazing capable of imparting gloss to hair, scalp, skin, nails, leather or fiber.

본 발명의 다른 목적은 상기 윤기 강화용 조성물을 포함하는 케어 제품을 제공하는데 있다.It is another object of the present invention to provide a care product comprising the composition for shine-hardening.

상기 과제를 해결하기 위한 수단으로서, 본 발명은 As means for solving the above problems,

트립토판(Trp), 히스티딘(His), 타이로신(Tyr), 페닐알라닌(Phe), 아르기닌(Arg), 시스테인(Cys), 메티오닌(Met), 알란토인(Allantoin) 및 이들의 유도체로 이루어진 군에서 선택된 하나 이상의 기능성 성분; 및 반응매개물질을 포함하는 윤기 강화용 조성물을 제공한다.At least one member selected from the group consisting of tryptophan (Trp), histidine (His), tyrosine (Tyr), phenylalanine (Phe), arginine (Arg), cysteine (Cys), methionine Functional ingredients; And a reaction medium.

또한, 본 발명은 상기 조성물을 포함하는 케어 제품을 제공한다.The present invention also provides a care product comprising the composition.

본 발명에 따른 윤기 강화용 조성물은 모발, 두피, 피부, 손발톱, 가죽 또는 섬유의 단백질과 공유결합이 가능한 하나 이상의 아민 혹은 카르복실 반응기를 갖는 기능성 성분이 함유되어 있어, 상기 단백질과 기능성 성분이 공유결합을 형성함으로써, 반영구적인 윤기 강화 효과를 제공해 준다.The composition for shine-strengthening according to the present invention contains a functional ingredient having at least one amine or carboxyl-reactive group capable of covalently bonding with proteins of hair, scalp, skin, nail, leather or fiber, By forming a bond, it provides a semi-permanent shine-strengthening effect.

본 발명은 트립토판(Trp), 히스티딘(His), 타이로신(Tyr), 페닐알라닌(Phe), 아르기닌(Arg), 시스테인(Cys), 메티오닌(Met), 알란토인(Allantoin) 및 이들의 유도체로 이루어진 군에서 선택된 하나 이상의 기능성 성분; 및 반응매개물질을 포함하는 윤기 강화용 조성물에 관한 것이다.The present invention relates to a pharmaceutical composition comprising a compound selected from the group consisting of tryptophan (Trp), histidine (His), tyrosine (Tyr), phenylalanine (Phe), arginine (Arg), cysteine (Cys), methionine One or more functional ingredients selected; And a reaction medium.

본 발명에 있어서, '윤기 강화용 조성물'이라 함은 윤기 부여 특성이 우수한 기능성 성분과 모발, 두피, 손발톱, 피부, 가죽 또는 섬유 단백질의 구성 성분으로 다량 존재하는 카르복실기와 아민기를 공유결합시킴으로써 단백질의 표면을 개질하여 점진적, 반영구적인 효과를 얻어내므로 윤기 발현 효과를 극대화 시킬 수 있다. 또한, 모발 색상의 선명도 향상, 염색 모발의 색상 선명도 향상, 모발 윤택도 향상, 염색 모발의 윤택도 향상 등의 부수적인 효과까지 얻을 수 있도록 하는 조성물을 의미한다.In the present invention, the term 'composition for improving glossiness' refers to a composition having a functional ingredient having excellent gloss-imparting properties and a carboxyl group and an amine group covalently bonded to a large amount of a carboxyl group and an amine group as constituents of hair, scalp, nail, skin, The surface is modified to obtain progressive and semi-permanent effects, thereby maximizing the effect of glossiness. It also means a composition capable of obtaining additional effects such as improvement of sharpness of hair color, improvement of color clarity of dyed hair, improvement of hair elasticity, improvement of the durability of hair dye.

상기 "윤기 강화용 조성물"은 모발 윤기 강화용 조성물, 두피 윤기 강화용 조성물, 피부 윤기 강화용 조성물, 손발톱 윤기 강화용 조성물, 가죽 윤기 강화용 조성물 및/또는 섬유 윤기 강화용 조성물을 포함할 수 있다.The above-mentioned "composition for glaze strengthening" may include a composition for hair glaze strengthening, a composition for scalp glaze strengthening, a composition for skin glaze strengthening, a composition for nail glaze strengthening, a composition for leather glaze strengthening and / .

본 발명에 따른 윤기 강화용 조성물은, 예를 들면, 단백질로 구성된 기질과 기능성 성분을 반응매개물질을 통해 반응시켜 단백질로 구성된 기질과 기능성 성분을 반응하게 함으로써 단백질 기질의 카르복실기와 기능성 성분의 아민기, 단백질 기질의 아민기와 기능성 성분의 카르복실기 및/또는 단백질 기질의 아민기와 기능성 성분의 아민기를 공유결합시킴으로써 윤기 강화 효과를 반영구적으로 극대화시킬 수 있다.The composition for lubricity enhancement according to the present invention can be obtained by, for example, reacting a substrate composed of a protein with a functional ingredient through a reaction medium to react with a substrate composed of a protein and a functional ingredient to form a carboxyl group of the protein substrate and an amine group , The amino group of the protein substrate and the amino group of the carboxyl group of the functional ingredient and / or the protein substrate and the amine group of the functional ingredient are covalently bonded to maximize the gloss enhancement effect.

본 발명에 있어서, '단백질로 구성된 기질'이라 함은 예를 들면, 모발, 두피, 피부, 손발톱, 가죽 및 섬유 등을 포함하지만, 이에 한정되는 것은 아니다.In the present invention, the term "substrate composed of protein" includes, but is not limited to, for example, hair, scalp, skin, nail, leather and fiber.

본 발명에 있어서, '기능성 성분'이라 함은 구조 내에 탄소와 질소로 형성된 단일 또는 한 개 이상의 고리 구조를 포함하고, 동시에 하나 이상의 카르복실기와 아민기를 갖는 성분으로, 예를 들면, 트립토판, 히스티딘, 타이로신, 페닐알라닌, 아르기닌, 시스테인 및 메티오닌을 포함하는 아미노산; 및 알란토인 및 이들의 유도체로 이루어진 군에서 선택된 하나 이상의 기능성 성분을 포함할 수 있다.In the present invention, the term 'functional component' refers to a component having a single or at least one cyclic structure formed of carbon and nitrogen in the structure, and having at least one carboxyl group and an amine group at the same time, for example, tryptophane, histidine, tyrosine , Phenylalanine, arginine, cysteine, and methionine; And allantoin and derivatives thereof. ≪ Desc / Clms Page number 7 >

상기 기능성 성분은 전체 조성물 100 중량부에 대하여 0.000001 내지 30 중량부, 예를 들어, 0.001 내지 15 중량부, 0.01 내지 5 중량부, 0.1 내지 3 중량부를 사용할 수 있다. 상기 기능성 성분의 함량이 0.000001 중량부 미만이면 지속적인 윤기 효과가 나타나기 어려운 문제가 있으며, 30 중량부를 초과하면 기능성 성분의 용해도에 의해서 용해가 불가하거나 제형에서 석출되는 등의 안정성 문제가 있을 수 있다.The functional ingredient may be used in an amount of 0.000001 to 30 parts by weight, for example, 0.001 to 15 parts by weight, 0.01 to 5 parts by weight, and 0.1 to 3 parts by weight based on 100 parts by weight of the total composition. If the content of the functional ingredient is less than 0.000001 parts by weight, there is a problem that the continuous gloss effect is hard to be exhibited. If the content exceeds 30 parts by weight, there may be a stability problem such that dissolution is impossible due to solubility of the functional ingredient or precipitation from the formulation.

본 발명에 있어서, 상기 반응매개물질은 카르보디이미드계 화합물, 디하이드록시퀴놀린계 화합물, 아미늄계 화합물 및 포스포늄계 화합물로 이루어진 군에서 선택된 하나 이상을 포함한다.In the present invention, the reaction medium material includes at least one selected from the group consisting of a carbodiimide compound, a dihydroxyquinoline compound, an aminium compound, and a phosphonium compound.

상기 카르보디이미드계 화합물은 분자 내에 하나 이상의 메탄디이민(-N=C=N-)을 포함하는 화합물로 하기 화학식 1로 표시되는 성분을 포함할 수 있다:The carbodiimide-based compound may contain at least one methane diimine (-N = C = N-) in the molecule, and may be represented by the following formula (1)

[화학식 1][Chemical Formula 1]

Figure pat00001
Figure pat00001

상기 화학식 1에서, A는

Figure pat00002
,
Figure pat00003
,
Figure pat00004
,
Figure pat00005
,
Figure pat00006
,
Figure pat00007
,
Figure pat00008
,
Figure pat00009
,
Figure pat00010
,
Figure pat00011
,
Figure pat00012
,
Figure pat00013
, ,
Figure pat00015
,
Figure pat00016
,
Figure pat00017
,
Figure pat00018
,
Figure pat00019
,
Figure pat00020
,
Figure pat00021
Figure pat00022
로 이루어진 군에서 선택된 하나 이상의 구조를 가지는 것으로, 반복 단위 양 말단에 이소시아네이트(*)기를 갖는 모노머이고, R은 수소; 또는 탄소수 1 내지 500의 직쇄, 분지쇄 또는 고리형의 탄화수소; 또는 벤젠 고리형의 탄화수소;를 나타내며, 상기 탄화수소 분자의 일부에 이중결합을 포함하거나; O, N, S, P 및 Si로 이루어진 군에서 선택된 하나 이상의 화합물이 치환된 형태이거나; 음이온, 양이온, 양쪽성 형태로 치환된 형태이거나; 또는 금속이온이 염 형태로 결합된 구조를 포함하고, m은 1 내지 100의 정수이다.In the above formula (1), A represents
Figure pat00002
,
Figure pat00003
,
Figure pat00004
,
Figure pat00005
,
Figure pat00006
,
Figure pat00007
,
Figure pat00008
,
Figure pat00009
,
Figure pat00010
,
Figure pat00011
,
Figure pat00012
,
Figure pat00013
, ,
Figure pat00015
,
Figure pat00016
,
Figure pat00017
,
Figure pat00018
,
Figure pat00019
,
Figure pat00020
,
Figure pat00021
And
Figure pat00022
(*) Group at both terminals of the repeating unit, and R is hydrogen; A straight chain, branched chain or cyclic hydrocarbon having 1 to 500 carbon atoms; Or a benzene ring-type hydrocarbon, and the hydrocarbon molecule includes a double bond in a part of the molecule; At least one compound selected from the group consisting of O, N, S, P, and Si is substituted; Anion, cation, amphoteric form; Or a structure in which metal ions are bonded in the form of a salt, and m is an integer of 1 to 100.

상기 카르보디이미드계 화합물은 1,1'-메틸렌-비스-(3-이소시아네이토사이클로헥산)-, 호모폴리머, 폴리에틸렌 글리콜 모노-Me-에테르-블록트(1,1'-methylene-bis-(4-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked), 1,1'-메틸렌-비스-(4-이소시아네이토사이클로헥산)-, 호모폴리머, 폴리에틸렌 글리콜 모노-Me-에테르-블록트(1,1'-methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked), 1,1'-메틸렌-비스-(4-이소시아네이토사이클로헵탄)-, 호모폴리머, 폴리에틸렌 글리콜 모노-Me-에테르-블록트(1,1'-methylene-bis-(4-isocyanatocycloheptane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked, 1,1'-메틸렌-비스-(3-이소시아네이토사이클로헵탄)-, 호모폴리머, 폴리에틸렌 글리콜 모노-Me-에테르-블록트(1,1'-methylene-bis-(3-isocyanatocycloheptane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked), 1,1'-메틸렌-비스-(3-이소시아네이토사이클로펜탄)-, 호모폴리머, 폴리에틸렌 글리콜 모노-Me-에테르-블록트(1,1'-methylene-bis-(3-isocyanatocyclopentane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked), 벤젠, 1,3,-비스(1-이소시아네이토-1-메틸에틸)-, 호모폴리머, 폴리에틸렌 글리콜 모노-메-에테르-블록트(Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blocked), 1-에틸-3-(3-디메틸아미노프로필)카르보디이미드(1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide) 및 1-에틸-3-(3-디메틸아미노프로필)카르보디이미드HCl(1-Ethyl-3-(3-dimethylaminopropyl)carbodiimideHCl)로 이루어진 군에서 선택된 하나 이상을 포함할 수 있으나, 이에 제한되는 것은 아니다.The carbodiimide-based compound may be selected from the group consisting of 1,1'-methylene-bis- (3-isocyanatocyclohexane) -, homopolymer, polyethylene glycol mono-Mee- - (4-isocyanatocyclohexane) -, homopolymer, polyethylene glycol mono-Me-ether-blocked, 1,1'-methylenebis- (4-isocyanatocyclohexane) -, homopolymer, polyethylene glycol mono-Me (3-isocyanatocyclohexane), homopolymer, polyethylene glycol mono-Me-ether-blocked, 1,1'-methylene-bis- 1-methylene-bis- (4-isocyanatocycloheptane) -, homopolymer, polyethylene glycol mono-Me-ether-blocked, 1, (1-methylene-bis- (3-isocyanatocycloheptane) -, homopolymer, polyethylene glycol mono-Mee- , polyethylene glyco l-mono-Me-ether-blocked, 1,1'-methylene-bis- (3-isocyanatocyclopentane) -, homopolymer, polyethylene glycol mono-Me- methylene-bis- (3-isocyanatocyclopentane) -, homopolymer, polyethylene glycol mono-Me-ether-blocked, benzene, 1,3 bis bis (1-isocyanato- Ethyl-3- (3-bis (1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether- 3- (3-dimethylaminopropyl) carbodiimide and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide HCl (1-Ethyl- dimethylaminopropyl) carbodiimide HCl), but it is not limited thereto.

한 구체예에서, 반응매개물질로 벤젠, 1,3,-비스(1-이소시아네이토-1-메틸에틸)-, 호모폴리머, 폴리에틸렌 글리콜 모노-메-에테르-블록트(Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blocked) 또는 1,1'-메틸렌-비스-(3-이소시아네이토사이클로헥산)-, 호모폴리머, 폴리에틸렌 글리콜 모노-Me-에테르-블록트(1,1'-methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked)의 카르보디이미드계 화합물을 사용할 수 있다.In one embodiment, the reaction medium is selected from the group consisting of benzene, 1,3, -bis (1-isocyanato-1-methylethyl) -, homopolymers, polyethylene glycol mono-ether- 3-bis (1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked or 1,1'-methylene- , And polyethylene glycol mono-Me-ether-blocked (carbodiimide) compounds of 1,1'-methylene-bis- ( 3- isocyanatocyclohexane) -, homopolymer and polyethylene glycol mono-Me-ether- .

상기 디하이드록시퀴놀린계 화합물은 하기 화학식 2로 표시되는 화합물일 수 있다:The dihydroxyquinoline-based compound may be a compound represented by the following Formula 2:

[화학식 2](2)

Figure pat00023
Figure pat00023

상기 화학식 2에서 R1은 수용성 비이온계 고분자; 비드 형태 및 레진 형태의 고분자 수지; 및 실리카 비드로 이루어진 군에서 선택된 하나이고, R2 및 R3는 각각 탄소수 1 내지 10의 직쇄; 또는 분지된 포화 알킬기; 또는 불포화 알킬기일 수 있다.Wherein R 1 is a water-soluble nonionic polymer; Polymeric resins in bead and resin form; And silica beads, and R 2 and R 3 are each a straight chain of 1 to 10 carbon atoms; Or branched saturated alkyl groups; Or an unsaturated alkyl group.

상기 수용성 비이온계 고분자는 분자량이 20,000 Da 미만인 폴리에틸렌글라이콜(PEG), 폴리비닐알콜(PVA), 폴리에틸렌옥사이드(PEO), 폴리아크릴로니트릴(PAN), 폴리비닐피롤리돈(PVP), 폴리이소프로필아크릴아미드(PNIPPAm), 셀룰로오스 유도체, 스타치 유도체, 덱스트란 및 구아검으로 이루어진 군에서 선택된 하나 이상의 고분자일 수 있으나, 이에 제한되는 것은 아니다. 상기 수용성 비이온계의 분자량이 20,000 Da 이상이면 공유결합을 유도하는 디하이드록시퀴놀린계 화합물의 비율이 너무 적어 윤기 효과를 나타내기 어려운 문제점이 있다.The water-soluble non-ionic polymer may be selected from the group consisting of polyethylene glycol (PEG), polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylonitrile (PAN), polyvinylpyrrolidone (PVP) But are not limited to, one or more polymers selected from the group consisting of polyisopropylacrylamide (PNIPPAm), cellulose derivatives, starch derivatives, dextran, and guar gum. If the molecular weight of the water-soluble nonionic system is 20,000 Da or more, the proportion of the dihydroxyquinoline-based compound which induces the covalent bond is too small to achieve a shiny effect.

상기 비드 형태 및 레진 형태의 고분자 수지는 분자량이 20,000 Da 미만인 스티렌, 에틸렌, 부타디엔, 아크릴로니트릴, 메틸스티렌, 테레프탈레이트, 염화에틸렌, 에테르케톤, 에테르이미드, 에테르설폰, 프탈아미드, 페닐렌에테르, 산화페닐렌, 페닐렌설파이드, 설폰, 우레탄, 비닐리덴플루오라이드 및 테트라플루오르에틸렌으로 이루어진 군에서 선택된 하나 이상의 단량체로 중합된 고분자일 수 있으나, 이에 제한되는 것은 아니다.The bead-shaped and resin-type polymer resin may be selected from the group consisting of styrene, ethylene, butadiene, acrylonitrile, methylstyrene, terephthalate, ethylene chloride, ether ketone, etherimide, ether sulfone, phthalamide, But are not limited to, polymers polymerized with one or more monomers selected from the group consisting of phenylene oxide, phenylene sulfide, sulfone, urethane, vinylidene fluoride and tetrafluoroethylene.

상기 비드 형태 및 레진 형태의 고분자 수지의 분자량이 20,000Da 이상이면 공유결합을 유도하는 디하이드록시퀴놀린계 화합물의 비율이 너무 적어 윤기 효과를 나타내기 어려운 문제점이 있다.When the molecular weight of the bead-shaped and resin-type polymer resin is 20,000 Da or more, the proportion of the dihydroxyquinoline-based compound that induces the covalent bond is too small to achieve a shiny effect.

상기 실리카 비드는 직경이 100㎚ 내지 1㎜, 예를 들어, 100㎚ 내지 100㎛, 1㎛ 내지 100㎛, 1㎛ 내지 70㎛인 것이 포함될 수 있다. 실리카 비드의 직경이 100㎚ 보다 작을 경우 피부 표면에서 안전성 문제를 일으킬 수 있으며, 실리카 비드의 직경이 1㎜ 보다 클 경우에는 제형화 및 안정화에 문제가 있다.The silica beads may include those having a diameter of 100 nm to 1 mm, for example, 100 nm to 100 탆, 1 탆 to 100 탆, and 1 탆 to 70 탆. If the diameter of the silica beads is less than 100 nm, safety problems may occur on the surface of the skin. If the diameter of the silica beads is larger than 1 mm, there is a problem in formulation and stabilization.

본 발명의 반응매개물질은 암모늄염(NH4 +) 또는 포스포늄염(PH4 +)의 수소 중 최소 하나 이상이 알킬기 또는 다른 유기그룹(organic group)으로 치환된 구조의 양이온화 화합물인 아미늄계 화합물 또는 포스포늄계 화합물을 포함할 수 있으나, 이에 제한되는 것은 아니다.The reaction mediator of the present invention is a reaction-mediating compound in which an aminium-based compound, which is a cationic compound having a structure in which at least one of hydrogen of an ammonium salt (NH 4 + ) or a phosphonium salt (PH 4 + ) is substituted with an alkyl group or another organic group Or a phosphonium-based compound.

상기 아미늄계 화합물은 N-[(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트 N-옥사이드(N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide), N-[(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로보레이트(N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluoroborate), 2-(3,4-(N-[(1H- 벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트 N-옥사이드(2-(3,4-(N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide), 2-(3,4-디하이드로-4-옥소-1,2,3-벤조트리아진-3-일)-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate), O-(3,4,-디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일)-1,1,3,3-테트라메틸우로늄 헥사플루오로보레이트(O-(3,4,-dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl)-1,1,3,3-tetramethyluronium hexafluoroborate), O-(3,4,-디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일)-1,1,3,3-테트라메틸우로늄 헥사플루오로포스페이트(O-(3,4,-dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), 2-(2-옥소-1(2H)-피리딜-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-(2-oxo-1(2H)-pyridyl-1,1,3,3-tetramethyluronium tetrafluoroborate), 2-(2-옥소-1(2H)-피리딜-1,1,3,3-테트라메틸우로늄 테트라플루오로포스페이트(2-(2-oxo-1(2H)-pyridyl-1,1,3,3-tetramethyluronium tetrafluorophosphate), 2-석시니미도-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-succinimido-1,1,3,3-tetramethyluronium tetrafluoroborate)), 2-석시니미도-1,1,3,3-테트라메틸우로늄 테트라플루오로포스페이트(2-succinimido-1,1,3,3-tetramethyluronium tetrafluorophosphate), N,N,N',N'-비스(테트라메틸렌-O-펜타플루오로페닐우로늄 테트라플루오로보레이트(N,N,N',N'-bis(tetramethylene-O-pentafluorophenyluronium tetrafluoroborate), N,N,N',N'-비스(테트라메틸렌-O-펜타플루오로페닐우로늄 헥사플루오로포스페이트(N,N,N',N'-bis(tetramethylene-O-pentafluorophenyluronium hexafluorophosphate), N-[6-트리플루오로메틸(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메트아미늄 테트라플루오로보레이트 N-옥사이드(N-[6-trifluoromethyl(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethaminium tetrafluoroborate N-oxide), N-[6- 트리플루오로메틸(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N- 메틸메트아미늄 헥사플루오로포스페이트 N-옥사이드(N-[6-trifluoromethyl(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethaminium hexafluorophosphate N-oxide), N-[(디메틸아미노)-1H-1,2,3-트리아졸로[4,5,b]피리딘-1-일]메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트 N-옥사이드(N-[(dimethylamino)-1H-1,2,3-triazolo[4,5,b]pyridin-1-yl]methylene]-N-methylmethanaminium hexafluorophosphate N-oxide), N-[(디메틸아미노)-1H-1,2,3-트리아졸로[4,5-b]피리딘-1-일메틸렌]-N-메틸메탄아미늄 테트라플루오로보레이트 N-옥사이드(N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminium tetrafluoroborate N-oxide), N-[(디메틸아미노)-1H-1,2,3- 트리아졸로[4,5-b]피리딘-1-일메틸렌]-N- 메틸메탄아미늄 헥사플루오로포스페이트 N-설파이드(N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminium hexafluorophosphate N-sulfide), S-(1-옥사이도-1-피리디닐)-1,1,3,3-테트라메틸티우로늄 헥사플루오로포스페이트(S-(1-oxido-1-pyridinyl)-1,1,3,3-tetramethylthiouronium hexafluorophosphate), O-[시아노(에톡시카르보닐)메틸렌아미노]-N,N,N',N'-테트라메틸우로늄 테트라플루오로보레이트(O-[cyano(ethoxycarbonyl)methyleneamino]-N,N,N',N'-tetramethyluronium tetrafluoroborate), O-[시아노(에톡시카르보닐)메틸렌아미노]-N,N,N',N'-테트라메틸티우로늄 헥사플루오로포스페이트(O-[cyano(ethoxycarbonyl)methyleneamino]-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-[(디시아노메틸리덴)-아미노]-1,1,3,3,-테트라메틸티우로늄 헥사플루오로포스페이트(O-[(dicyanomethylidene)-amino]-1,1,3,3,-tetramethyluronium hexafluorophosphate, O-[(디메톡시카르보닐메틸리덴)-아미노]-1,1,3,3,-테트라메틸티우로늄 헥사플루오로포스페이트(O-[(dimethoxycarbonylmethylidene)-amino]-1,1,3,3,-tetramethyluronium hexafluorophosphate), N-[(시아노(피리딘-2-일)메틸렌 아미노옥시) (디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트(N-[(cyano(pyridin-2-yl)methylene aminooxy)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate), 2-(5-노보넨-2,3-디카르복시미도)-1,1,3,3-테트라메틸티우로늄 테트라플루오로보레이트(2-(5-norbornene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate), 2-프탈이미도-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-phthalimido-1,1,3,3-tetramethyluronium tetrafluoroborate, 비스(테트라메틸렌)클로로포름아미디늄 헥사플루오로포스페이트(bis(tetramethylene)chloroformamidinium hexafluorophosphate), (1H-벤조트리아졸-1-일)(1-피롤리디닐메틸렌) 피롤리디늄 헥사플루오로포스페이트 N-옥사이드((1H-benzotriazol-1-yl)(1-pyrollidinylmethylene)pyrrolidinium hexafluorophosphate N-oxide), 1-(1-피롤리디닐-1H-1,2,3-트리아졸로[4,5-b]피리딘-1-일메틸렌) 피롤리디늄 헥사플루오로포스페이트 N-옥사이드(1-(1-pyrrolidinyl-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N-oxide), O-(3,4-디하이드로-4-옥소-1,2,3-벤조트리아진-3-일)-1,1,3,3-비스(테트라메틸렌)우라늄 헥사플루오로포스페이트(O-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-1,1,3,3-bis(Tetramethylene)uranium hexafluorophosphate), O-(3,4- 디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일)-1,1,3,3-비스(테트라메틸렌) 우라늄 헥사플루오로포스페이트(O-(3,4-Dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl)-1,1,3,3-bis(Tetramethylene) uranium hexafluorophosphate), N,N,N',N'-비스(테트라메틸렌)-O-펜타플루오로 페닐우로늄 헥사플루오로포스페이트(N,N,N',N'-bis(tetra methylene)-O-pentafluoro phenyluronium hexafluorphosphate), N,N,N',N'-비스(테트라메틸렌)-S-펜타플루오로사이오페닐우로늄 헥사플루오로포스페이트 (N,N,N',N'-bis(tetramethylene)-S-pentafluorothiophenyluronium hexafluorphosphate), 1-(1-피롤리디닐-1H-1,2,3-트리아졸로[4,5-b]피리딘-1-일메틸렌) 피롤리디늄 헥사플루오로포스페이트 N-설파이드(1-(1-pyrrolidinyl-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N-sulfide), N,N,N',N'-비스(테트라메틸렌)-O-2-니트로페닐우로늄 헥사플루오로포스페이트 (N,N,N',N'-bis(tetramethylene)-O-2-nitrophenyluronium hexafluorophosphate), N,N,N',N'-비스(테트라메틸렌)-O-펜타플루오로페닐우로늄 헥사플루오로포스페이트(N,N,N',N'-bis(tetramethylene)-O-pentafluorophenyluronium hexafluorohosphate), O-(벤조트리아졸-1-일)-1,1,3,3-비스(펜타메틸렌) 헥사플루오로포스페이트(O-(benzotriazol-1-yl)-1,1,3,3-bis(pentamethylene) hexafluorophosphate), O-(7-아자벤조트리아졸-1-일)-1,1,3,3-비스(펜타메틸렌)-우로늄 헥사플루오로포스페이트(O-(7-azabenzotriazol-1-yl)-1,1,3,3-bis(pentamethylene)-uronium hexafluorophosphate), 2-[2-옥소-1(2H)-피리딜]-1,1,3,3-비스(펜타메틸렌) 우로늄 테트라플루오로보레이트(2-[2-oxo-1(2H)-pyridyl]-1,1,3,3-bis(pentamethylene) uronium tetrafluoroborate), 2-클로로-1,3-디메틸이미다졸리디늄 헥사플루오로포스페이트(2-chloro-1,3-dimethylimidazolidinium hexafluorophosphate), O-(벤조트리아졸-1-일)-1,3-디메틸-1,3-디메틸렌 우로늄 헥사플루오로포스페이트(O-(benzotriazol-1-yl)-1,3-dimethyl-1,3-dimethylene uronium hexafluorophosphate), O-(7-아자벤조트리아졸-1-일)-1,3-디메틸-1,3-디메틸엔우로늄 헥사플루오로포스페이트(O-(7-azabenzotriazol-1-yl)-1,3-dimethyl-1,3-dimethyleneuronium hexafluorophosphate), 2-클로로-1,3-디메틸피리미디늄 헥사플루오로포스페이트(2-chloro-1,3-dimethylpyrimidinium hexafluorophosphate), O-(벤조트리아졸-1-일)-1,3-디메틸-1,3-트리메틸렌우로늄 헥사플루오로포스페이트(O-(benzotriazol-1-yl)-1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), O-(7- 아자벤조트리아졸-1-일)-1,3-디메틸-1,3-트리메틸렌우로늄 헥사플루오로포스페이트(O-(7-azabenzotriazol-1-yl)-1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), (7-벤조트리아졸-일)-1,1,3-트리메틸-1-헥사플루오로포스페이트((7-benzotriazol-yl)-1,1,3-tri methyl-1-hexafluorophosphate), (7-아자벤조트리아졸-일)-1,1,3- 트리메틸-1-페닐우로늄 헥사플루오로포스페이트((7-azabenzotriazol-yl)-1,1,3-trimethyl-1-phenyluronium hexafluorophosphate), O-(1H-벤조트리아졸-1-일)-1,1-디메틸-3,3-테트라메틸렌 우로늄 헥사플루오로포스페이트(O-(1H-benzotriazol-1-yl)-1,1-dimethyl-3,3-tetramethylene uronium hexafluorophosphate), O-(1H-1,2,3-트리아졸로[4,5-b]피리딘-일)-1,1-디메틸-3,3-테트라메틸렌우로늄 헥사플루오로포스페이트(O-(1H-1,2,3-triazolo[4,5-b]pyridin-yl)-1,1-dimethyl-3,3-tetramethyleneuronium hexafluorophosphate), O-(1H-벤조트리아졸-1-일)-1,1-디메틸-3,3-펜타메틸렌 우로늄 헥사플루오로포스페이트(O-(1H-benzotriazol-1-yl)-1,1-dimethyl-3,3-pentamethylene uronium hexafluorophosphate), 6-클로로-1((디메틸아미노)(모르폴리노)메틸렌)-1H-벤조 트리아졸리움 헥사플루오로포스페이트-3 옥사이드(6-chloro-1((dimethylamino)(morpholino)methylene)-1H-benzo triazolium hexafluorophosphate-3 oxide), 3-((디메틸아미노)-(모르폴리노)메틸렌)-1H-[1,2,3]트리아졸로[4,5-b]피리디늄 헥사플루오로포스페이트(3-((dimethylamino)-(morpholino)methylene)-1H-[1,2,3]triazolo[4,5-b]pyridinium hexafluorophosphate), 6-트리플루오로메틸-1-((디메틸아미노)-(모르폴리노)메틸렌)-1H-벤조트리아졸리움 헥사플루오로포스페이트-3-옥사이드(6-trifluoromethyl-1-((dimethylamino)-(morpholino)methylene)-1H-benzotriazolium hexafluorophsphate-3-oxide), 1-((디메틸아미노)-(모르폴리노)) 옥시펜타플루오로페닐메텐이미늄 헥사플루오로포스페이트(1-((dimethylamino)-(morpholino)) oxypentafluorophenylmetheniminium hexafluorophosphate), 1-[(1-(시아노-2-에톡시-2-옥소에틸리덴아미노옥시)-디메틸아미노 모르폴리노메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1-(cyano-2-ethoxy-2-oxoethylideneaminooxy)-dimethylamino morpholinomethylene)] methanaminium hexafluorophosphate), 1-[(1-(디시아노메틸렌아미노옥시) 디메틸아미노 모르폴리노메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1-(dicyanomethyleneaminooxy) dimethylamino morpholinomethylene)] methanaminium hexafluorophosphate), 1-[(1,3-디에톡시-1,3-디옥소프로판-2-일리덴아미노옥시) 디메틸아미노 모르폴리노메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1,3-diethoxy-1,3-dioxopropan-2-ylideneaminooxy) dimethylaminomorpholinomethylene)] methanaminium hexafluorophosphate), N-[(시아노(피리딘-2-일)메틸렌아미노옥시) (디메틸아미노)메틸렌]-N-모르폴리노메탄아미늄 헥사플루오로포스페이트(N-[(cyano(pyridin-2-yl)methyleneaminooxy) (dimethylamino)methylene]-N-morpholinomethanaminium hexafluorophosphate), 1-[(1-(시아노-2-에톡시-2-옥소에틸리덴아미노옥시)디메틸아미노피롤로디노 메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1-(cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylaminopyrrolodino methylene)]methanaminium hexafluorophosphate), 1-((디시아노메틸렌아미노옥시) 모르폴리노메틸렌)피롤리디늄 헥사플루오로포스페이트(1-((dicyanomethyleneaminooxy) morpholinomethylene)pyrrolidinium hexafluorophosphate), 1-[(1,3-디에톡시-1,3-디옥소프로판-2-일덴아미노옥시)-디메틸아미노-피롤로디노메틸렌]] 메탄아미늄 헥사플루오로포스페이트(1-[(1,3-diethoxy-1,3-dioxopropan-2-yldeneaminooxy)-dimethylamino-pyrrolodinomethylene]] methanaminium hexafluorophosphate), 1-[(1-(시아노-2-에톡시-2-옥소에틸리덴 아미노옥시)-디메틸아미노-피롤로디노메틸렌)]메탄아미늄 헥사플루오로포스페이트(1-[(1-(cyano-2-ethoxy-2-oxoethylidene aminooxy)-dimethylamino-pyrrolodinomethylene)]methanaminium hexafluororphosphate), 1-((1-시아노-2-에톡시-2-옥소에틸리덴아미노옥시)(모르폴리노)메틸렌)피롤리디늄 헥사플루오로포스페이트(1-((1-cyano-2-ethoxy-2-oxoethylideneaminooxy)(morpholino)methylene)pyrrolidinium hexafluorophospahte), 벤조트리아졸-1-일옥시-N,N-디메틸-메탄아미늄 헥사클로로안티모네이트(benzotriazol-1-yloxy-N,N-dimethyl-methanaminium hexachloroantimonate), 5-(1H-벤조트리아졸-1-일옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(1H-benzotriazol-1-yloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate), 5-(7-아자벤조트리아졸-1-일옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(7-azabenzotriazol-1-yloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate), 1-(1H-벤조트리아졸-1-일옥시)페닐-메틸렌 피롤리디늄 헥사클로로안티모네이트(1-(1H-benzotriazol-1-yloxy)phenyl-methylene pyrrolidinium hexachloroantimonate), 5-(펜타플루오로페닐옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(pentafluorophenyloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonite), 5-(석시니미딜옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(succinimidyloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate), 5-(3',4'-디하이드로-4'-옥소-1',2',3'-벤조트리아진-3'-일옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(3',4'-dihydro-4'-oxo-1',2',3'-benzotriazin-3'-yloxy)-3,4-diydro-1-methyl-2H-pyrrolium hexachloroantimonate) 및 이의 유도체로 이루어진 군에서 선택된 하나 이상일 수 있으나, 이에 제한되는 것은 아니다.The aminium-based compound is a compound represented by the following general formula (1): N - [(1H-benzotriazol-1-yl) (dimethylamino) methylene] -N- methylmethanaminiumhexafluorophosphate N- yl) (dimethylamino) methylene] -N-methylmethanaminium hexafluorophosphate N-oxide, N - [(1H-benzotriazol- - [(1H-benzotriazol-1-yl) (dimethylamino) methylene] -N-methylmethanaminium hexafluoroborate), 2- ] -N-methylmethanaminium hexafluorophosphate N-oxide (2- (3,4- (N - [(1H-benzotriazol- , 2- (3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate (2- 3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate), O- (3,4, 5-A Triazin-3-yl) -1,1,3,3-tetramethyluronium hexafluoroborate (O- (3,4-dihydro-4-oxo- 5- azabenzo-1,2,3-triazin-3-yl) -1,1,3,3-tetramethyluronium hexafluoroborate), O- (3,4-dihydro-4-oxo- 3-yl) -1,1,3,3-tetramethyluronium hexafluorophosphate (O- (3,4-dihydro-4-oxo-5-azabenzo- 3-triazin-3-yl) -1,1,3,3-tetramethyluronium hexafluorophosphate, 2- (2-oxo-1 (2H) -pyridyl-1,1,3,3-tetramethyluronium tetrafluoro (2-oxo-1 (2H) -pyridyl-1,1,3,3-tetramethyluronium tetrafluoroborate), 2- (2- (2-oxo-1 (2H) -pyridyl-1,1,3,3-tetramethyluronium tetrafluorophosphate), 2-succinimidyl-1,1,3,3-tetramethyluronium tetrafluorophosphate 2-succinimido-1,1,3,3-tetramethyluronium tetrafluoroborate), 2-succinimido-1,1,3,3-tetramethyluronium tetrafluoro Tetramethyluronium tetrafluorophosphate, N, N, N ', N'-bis (tetramethylene-O-pentafluorophenyluronium tetrafluoroborate (N, N N, N ', N'-bis (tetramethylene-O-pentafluorophenyluronium tetrafluoroborate), N, N'-bis (tetramethylene-O-pentafluorophenyluronium hexafluorophosphate), N- [6-trifluoromethyl (1H-benzotriazol- 1-yl) (dimethylamino) methylene] -N- methylmethaminium tetrafluoro (Dimethylamino) methylene] -N-methylmethaminium tetrafluoroborate N-oxide, N- [6-trifluoromethyl (1H-benzotriazol- 1-yl) (dimethylamino) methylene] -N-methylmethaminium hexafluorophosphate N-oxide (N- methylmethaminium hexafluorophosphate N-oxid e), N - [(dimethylamino) -1H-1,2,3-triazolo [4,5, b] pyridin- 1 -yl] methylene] -N- methylmethanaminium hexafluorophosphate N- N-methylmethanaminium hexafluorophosphate N-oxide, N - [(dimethylamino) -1H-1,2,3-triazolo [4,5, b] pyridin- 1H-1,2,3-triazolo [4,5-b] pyridin-1-ylmethylene] -N-methylmethanaminium tetrafluoroborate N-oxide (N - [(dimethylamino) 2,3-triazolo [4,5-b] pyridin-1-ylmethylene] -N-methylmethanaminium tetrafluoroborate N-oxide), N - [(dimethylamino) -1H-1,2,3-triazolo [ -b] pyridin-1-ylmethylene] -N-methylmethanaminium hexafluorophosphate N-sulfide (N - [(dimethylamino) -1H-1,2,3-triazolo [ 1-ylmethylene] -N-methylmethanaminium hexafluorophosphate N-sulfide, S- (1-oxydo-1-pyridinyl) -1,1,3,3-tetramethylthiuorium hexafluorophosphate (S- -oxido-1-pyridinyl) -1,1,3,3-tetramethylthiouronium hexafluorophospha N, N ', N'-tetramethyluronium tetrafluoroborate (O- [cyano (ethoxycarbonyl) methyleneamino] -N, N , N ', N'-tetramethyluronium tetrafluoroborate), O- [cyano (ethoxycarbonyl) methyleneamino] -N, N, N', N'-tetramethylthuronium hexafluorophosphate N, N ', N'-tetramethyluronium hexafluorophosphate, O - [(dicyanomethylidene) -amino] -1,1,3,3, - tetramethylthauronium hexafluorophosphate (O - [(dicyanomethylidene) -amino] -1,1,3,3, -tetramethyluronium hexafluorophosphate, O - [(dimethoxycarbonylmethylidene) -amino] -1,1,3,3, (Dimethoxycarbonylmethylidene) -amino] -1,1,3,3-tetramethyluronium hexafluorophosphate), N - [(cyano (pyridin-2- yl) methyleneaminooxy) (dimethylamino ) Methylene] -N-methylmethanaminium hexafluorophosphate (N - [(cyano (py ridin-2-yl) methylene aminooxy) (dimethylamino) methylene] -N-methylmethanaminium hexafluorophosphate), 2- (5-norbornene-2,3-dicarboximido) -1,1,3,3- 2- (5-norbornene-2,3-dicarboximido) -1,1,3,3-tetramethyluronium tetrafluoroborate), 2- phthalimido-1,1,3,3-tetramethyluronium Tetramethyluronium tetrafluoroborate, bis (tetramethylene) chloroformamidinium hexafluorophosphate, 2-phthalimido-1,1,3,3-tetramethyluronium tetrafluoroborate, bis (tetramethylene) chloroformamidinium hexafluorophosphate, (1-pyrrolidinylmethylene) pyrrolidinium hexafluorophosphate N-oxide), 1- (1-pyrrolidinylmethylene) pyrrolidinium hexafluorophosphate N-oxide, 1H-1,2, 3-triazolo [4,5-b] pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N-oxide (1- 3-triazolo [4,5-b] pyridin-1-ylmethyl] (pyrrolidinium hexafluorophosphate N-oxide), O- (3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3- (3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-bis (tetramethylene) uranium hexafluorophosphate), O - (3,4-dihydro-4-oxo-5-azabenzo-1,2,3-triazine-3- yl) -1,1,3,3-bis (tetramethylene) uranium hexafluorophosphate (3,4-Dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl) -1,1,3,3-bis (tetramethylene) uranium hexafluorophosphate), N, N , N ', N'-bis (tetramethylene) -O-pentafluorophenyluronium hexafluorophosphate (N, N', N'- , N, N ', N'-bis (tetramethylene) -S-pentafluorothiophenyluronium hexafluorophosphate), N, N' 1- (1-pyrrolidinyl-1H-1,2,3-triazolo [4,5-b ] Pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate (1-pyrrolidinyl-1H-1,2,3-triazolo [4,5- b] pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N, N ', N'-bis (tetramethylene) -O-2-nitrophenyluronium hexafluorophosphate -2-nitrophenyluronium hexafluorophosphate, N, N, N'-bis (tetramethylene) -O-pentafluorophenyluronium hexafluorophosphate, O-pentafluorophenyluronium hexafluorohosphate), O- (benzotriazol-1-yl) -1,1,3,3-bis (pentamethylene) hexafluorophosphate , 3,3-bis (pentamethylene) hexafluorophosphate, O- (7-azabenzotriazol-1-yl) -1,1,3,3-bis (pentamethylene) -ouronium hexafluorophosphate (2-oxo-1 (2H) -pyridyl] -1,1,3,3-bis (pentamethylene) -uronium hexafluorophosphate) - bis (pentamethylene) uranium Tetrafluoroborate (2- [2-oxo-1 (2H) -pyridyl] -1,1,3,3-bis (pentamethylene) uronium tetrafluoroborate), 2-chloro-1,3-dimethylimidazolidinium hexa (2-chloro- 1,3-dimethylimidazolidinium hexafluorophosphate), O- (benzotriazol-1-yl) -1,3-dimethyl-1,3-dimethylen uronium hexafluorophosphate benzotriazol-1-yl) -1,3-dimethyl-1,3-dimethylene uronium hexafluorophosphate), O- (7-azabenzotriazol- 1-yl-1,3-dimethyl-1,3-dimethyleneuronium hexafluorophosphate), 2-chloro-1,3-dimethylpyrimidinium hexafluorophosphate (2-chloro-1,3-dimethylpyrimidinium hexafluorophosphate) -chloro-1,3-dimethylpyrimidinium hexafluorophosphate, O- (benzotriazol-1-yl) -1,3-dimethyl-1,3-trimethylene uronium hexafluorophosphate ) -1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate, O- (7-azabenzotriazol-1-yl) (7-azabenzotriazol-1-yl) -1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), (7-benzotriazol- (7-benzotriazol-yl) -1,1,3-tri methyl-1-hexafluorophosphate), (7-azabenzotriazol- , 1, 3-trimethyl-1-phenyluronium hexafluorophosphate), O- (1H-benzotriazol- 1,1-dimethyl-3,3-tetramethylene uronium hexafluorophosphate (O- (1H-benzotriazol-1-yl) -1,1-dimethyl-3,3-tetramethylene uronium hexafluorophosphate), O - (1H-1,2,3-triazolo [4,5-b] pyridin-1-yl) - 1,1- dimethyl-3,3-tetramethyleneuronium hexafluorophosphate (O- 2,3-triazolo [4,5-b] pyridin-yl) -1,1-dimethyl-3,3-tetramethyleneuronium hexafluorophosphate, O- (1H-benzotriazol- -3,3-pentamethylene uronium hexafluoro Benzoquinolin-1-yl) -1,1-dimethyl-3,3-pentamethylene uronium hexafluorophosphate), 6-chloro-1 ((dimethylamino) (morpholino) methylene) 3 - ((dimethylamino) - (morpholino) methylene) -1H-benzo triazolium hexafluorophosphate-3 oxide, -1H- [1,2,3] triazolo [4,5-b] pyridinium hexafluorophosphate (3 - ((dimethylamino) - (morpholino) methylene) -1H- [1,2,3] triazolo [ 4,5-b] pyridinium hexafluorophosphate, 6-trifluoromethyl-1 - ((dimethylamino) - (morpholino) methylene) -1H-benzotriazolium hexafluorophosphate- 1 - ((dimethylamino) - (morpholino) methylene) -1H-benzotriazolium hexafluorophosphate-3-oxide), 1 - ((dimethylamino) - (morpholino)) oxypentafluorophenylmetheniminium hexafluorophosphate (1 - ((dimethylamino) - (morpholino)) oxype (1 - [(1-cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylaminomorpholinomethylene)] methanaminium hexafluorophosphate - (cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylamino morpholinomethylene)] methanaminium hexafluorophosphate), 1 - [(1- (dicyanomethyleneaminooxy) dimethylaminomorpholinomethylene)] methanaminium hexafluorophosphate 1 - [(1-dicyanomethyleneaminooxy) dimethylamino morpholinomethylene]] methanaminium hexafluorophosphate), 1 - [(1,3-diethoxy-1,3-dioxopropane-2-ylideneaminooxy) dimethylamino morpholinomethylene) 2-ylideneaminooxy)] methanaminium hexafluorophosphate), N - [(cyano (pyridin-2-yl) methylene) Aminooxy) (dimethylamino) methylene] -N-morpholinomethanaminium hexafluoro 1 - [(1- (cyano-2-ethoxy-2-oxoethylidene) methylene] amino] methylene] -N-morpholinomethanaminium hexafluorophosphate) 2-ethoxy-2-oxoethylideneaminooxy) dimethylaminopyrrolodino methylene]] methanaminium hexafluorophosphate), 1 - ((dicyano (Dicyanomethyleneaminooxy) morpholinomethylene) pyrrolidinium hexafluorophosphate), 1 - [(1,3-diethoxy-1,3-dioxopropane-2- (1 - [(1,3-diethoxy-1,3-dioxopropan-2-yldeneaminooxy) -dimethylamino-pyrrolodinomethylene]] methanaminium hexafluorophosphate ), 1 - [(1- (cyano-2-ethoxy-2-oxoethylideneminooxy) -dimethylamino- (1-cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylamino-pyrrolodinomethylene)] methanaminium hexafluorophosphate), 1- 2-ethoxy-2-oxoethylideneaminooxy) (morpholino) methylene) pyrrolidinium hexafluorophosphate (1-cyano- pyrrolidinium hexafluorophosphate, benzotriazole-1-yloxy-N, N-dimethyl-methanaminium hexachloroantimonate, 5- (1H-benzo (1H-benzotriazol-1-yloxy) -3,4-dihydro-1-methyl-2H- methyl-2H-pyrrolium hexachloroantimonate), 5- (7-azabenzotriazol-1-yloxy) -3,4-dihydro- azabenzotriazol-1-yloxy) -3,4-dihydro-1-methyl-2H-pyrrole hexachlor 1- (1H-benzotriazol-1-yloxy) phenyl-methylene pyrrolidinium hexachloroantimonate), 5- ( (Pentafluorophenyloxy) -3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonite), 5- (succinimidyloxy) -3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate (5- (succinimidyloxy) -3,4-dihydro- ), 5- (3 ', 4'-dihydro-4'-oxo-1', 2 ', 3'- benzotriazin-3'-yloxy) -3,4- dihydro- 2H-pyrrole hexachloroantimonate (5- (3 ', 4'-dihydro-4'-oxo-1', 2'3'-benzotriazin-3'-yloxy) -3,4- -methyl-2H-pyrrolium hexachloroantimonate) and derivatives thereof, but is not limited thereto.

상기 포스포늄계 화합물은 벤조트리아졸-1-일옥시트리스(디메틸아미노) 포스포늄 헥사플루오로포스페이트(benzotriazol-1-yloxytris(dimethylamino) phosphonium hexafluorophosphate), 브로모트리스 (디메틸아미노)포스포늄 헥사플루오로포스페이트(bromotris (dimethylamino)phosphonium hexafluorophosphate), 클로로트리 (피롤리디노) 포스포늄 헥사플루오로포스페이트 (chlorotri (pyrrolidino) phosphonium hexafluorophosphate), 브로모트리 (피롤리디노) 포스포늄 헥사플루오로포스페이트(bromotri (pyrrolidino) phosphonium hexafluorophosphate), 클로로트리스 (디메틸아미노) 포스포늄 헥사플루오로포스페이트(chloro-tris (dimethylamino) phosphonium hexafluorophosphate), 벤조트리아졸-1-일옥시트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트(benzotriazol-1-yloxytris (pyrrolidino) phosphonium hexafluorophosphate), [(7-아자벤조트리아졸-1-일)옥시]트리스-(디메틸아미노) 포스포늄 헥사플루오로포스페이트([(7-azabenzotriazol-1-yl)oxy]tris-(dimethylamino) phosphonium hexafluorophosphate), [(7-아자벤조트리아졸-1-일)옥시]트리스-(피롤리디노) 포스포늄 헥사플루오로포스페이트([(7-azabenzotriazol-1-yl)oxy]tris-(pyrrolidino) phosphonium hexaflurophosphate), O-[(시아노-(에톡시카르보닐)메틸리덴)-아미노]-일옥시트리스피롤리디노 포스포늄 헥사플루오로포스페이트(O-[(cyano-(ethoxycarbonyl)methyliden)-amino]- yloxytripyrrolidino phosphonium hexafluorophosphate), [(6-니트로벤조트리아졸―일)옥시]트리스-(피롤리디노) 포스포늄 헥사플루오로포스페이트([(6-nitrobenzotriazol―yl)oxy]tris-(pyrrolidino) phosphonium hexafluorophosphate), [(6-트리플루오로메틸)벤조트리아졸-1-일]-옥시 트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트([[(6-trifluoromethyl)benzotriazol-1-yl]oxy-tris(pyrrolidino)phosphonium hexafluorophosphate), [4-니트로-6-(트리플루오로메틸) 벤조트리아졸-1-일]옥시] 트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트([4-nitro-6-(trifluoromethyl)benzotriazol-1-yl]oxy] tris(pyrrolidino) phosphonium hexafluorophosphate), (6-클로로-벤조트리아졸-1-일옥시) 트리스 (피롤리디노) 포스포늄 헥사플루오로포스페이트((6-chloro-benzotriazol-1-yloxy)tris (pyrrolidino)-phosphonium hexafluorophosphate), N',N',N',N'-비스(테르라메틸렌)-O-펜타플루오로 페닐우로늄 헥사플루오로포스페이트(N',N',N',N'-bis(tetramethylene)-O-pentafluoro phenyluronium hexafluorophosphate), (피리딜-2-티오)트리스 (피롤리디노) 포스포늄 헥사플루오로포스페이트((pyridyl-2-thio)tris (pyrrolidino)-phosphonium hexafluorophosphate), [(3,4-디하이드로-4-옥소-1,2,3-벤조트리아진-3-일)옥시]트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트([(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)oxy]tris-(pyrrolidino)phosphonium hexafluorophosphate), [(3,4-디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일] 트리스 (피롤리디노) 포스포늄 헥사플루오로포스페이트([(3,4-dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl] tris-(pyrrolidino) phosphonium hexafluorophosphate) 및 이의 유도체로 이루어진 군에서 선택된 하나 이상일 수 있으나, 이에 제한되는 것은 아니다.The phosphonium-based compound may be at least one selected from the group consisting of benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphate, benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphate, bromotris (dimethylamino) phosphonium hexafluoro (Bromotri (dimethylamino) phosphonium hexafluorophosphate), chlorotri (pyrrolidino) phosphonium hexafluorophosphate, bromotri (pyrrolidino) phosphonium hexafluorophosphate, bromotri ) phosphonium hexafluorophosphate, chloro-tris (dimethylamino) phosphonium hexafluorophosphate, benzotriazol-1-yloxytris (pyrrolidino) phosphonium hexafluorophosphate -1-yloxytris (pyrrolidino) phosphonium hexafluorophosphate), [(7-azabenzotriazol- (Dimethylamino) phosphonium hexafluorophosphate), [(7-azabenzotriazol-1-yl) oxy] [(7-azabenzotriazol-1-yl) oxy] tris- (pyrrolidino) phosphonium hexaflurophosphate), O - [(cyano- (ethoxycarbonyl) Methylidene) -amino] -yloxytrispyrrolidinophosphonium hexafluorophosphate (O - [(cyano- (ethoxycarbonyl) methyliden) -amino] -yloxytripyrrolidino phosphonium hexafluorophosphate), [ (6-nitrobenzotriazol-yl) oxy] tris- (pyrrolidino) phosphonium hexafluorophosphate), [(6-trifluoromethyl) benzotriazole- -Yl] -oxytris (pyrrolidino) phosphonium hexafluorophosphate ([[(6-trifluoromethyl) benzotriazol-1-yl] oxy-tris (pyrrolidino) phosphonium hexafluorophosphate), [4-nitro-6- (trifluoromethyl) benzotriazol-1-yl] oxy] (6-chloro- benzothiazol-1-yloxy) tris (pyrrolidino) phosphonium hexafluorophosphate, benzotriazol-1-yloxy) tris (pyrrolidino) -phosphonium hexafluorophosphate), N ', N', N ', N'-bis (terrhymethylene )- O-pentafluorophenyluronium hexafluorophosphate (Pyridyl-2-thio) tris (pyrrolidino) phosphonium hexafluorophosphate, N, (pyrrolidino) -phosphonium hexafluorophosphate), [(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3- yl) oxy] tris (pyrrolidino) phosphonium hexafluorophosphate [(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) oxy] tris- (pyrrolidino) phosphonium hexafluorophosphate, Triazin-3-yl] tris (pyrrolidino) phosphonium hexafluorophosphate ([(3,4-dihydro-4-oxo-5-azabenzo-1,2,3 -triazin-3-yl] tris- (pyrrolidino) phosphonium hexafluorophosphate) and derivatives thereof, but is not limited thereto.

상기 반응매개물질은 전체 조성물 100 중량부에 대하여 0.000001 내지 10 중량부, 0.001 내지 7 중량부, 0.01 내지 5 중량부, 0.05 내지 3 중량부를 사용할 수 있다. 상기 반응매개물질의 함량이 0.000001 중량부 미만이면 지속적인 표면 개질 효과가 나타나기 어려운 문제가 있으며, 10 중량부를 초과하면 단백질로 구성된 기질에 존재하는 반응위치 이상으로 과도하게 존재하는 반응매개물질이 단백질 기질과 반응하지 못한 상태에서 기능성 성분과 반응함으로써 윤기 부여의 지속성 향상에 도움이 되지 못하고 오히려 손실되는 성분으로 작용할 수 있는 문제가 있다.The reaction medium may be used in an amount of 0.000001 to 10 parts by weight, 0.001 to 7 parts by weight, 0.01 to 5 parts by weight and 0.05 to 3 parts by weight based on 100 parts by weight of the total composition. If the content of the reaction mediator is less than 0.000001 parts by weight, there is a problem that the effect of continuous surface modification is hardly exhibited. If the amount exceeds 10 parts by weight, a reaction medium excessively present at a reaction site existing in a protein- There is a problem in that it can act as a lost component rather than improving the persistence of gloss imparting by reacting with the functional ingredient in the unreacted state.

상기 반응시에는 pH 2 내지 pH 12의 조건에서 반응이 가능하며, 보다 바람직하게는, pH 3 내지 pH 10에서 반응하는 것이 바람직하고, 가장 바람직하게는 pH 4.5 내지 pH 7의 약산성의 수용액 상에서 반응하는 것이 가장 반응 효율을 증대시킬 수 있다. 상기 반응은 1분 내지 30분 이내 완결된다.In the reaction, the reaction can be carried out at a pH of from 2 to 12, more preferably at a pH of from 3 to 10, and most preferably at a pH of from 4 to 7 in a weakly acidic aqueous solution Which can increase the reaction efficiency most. The reaction is completed within 1 minute to 30 minutes.

상기 조성물은 도포, 산포, 희석, 기타 이들에 유사한 방법으로 사용할 수 있다.The composition may be applied by application, dispersion, dilution, or the like.

한 구체예에서, 반응매개물질로 카르보디이미드계 화합물을 이용하여 단백질로 구성된 기질의 표면의 카르복실기와 기능성 성분의 아민기 사이의 반응을 하기 반응식 1에, 단백질로 구성된 기질의 표면의 아민기와 기능성 성분의 카르복실기 사이의 반응을 하기 반응식 2에 도식화하였다.In one embodiment, a reaction between a carboxyl group on the surface of a substrate composed of a protein and an amine group of a functional ingredient using a carbodiimide-based compound as a reaction mediator is shown in the following reaction formula 1 in which the amine group on the surface of the protein- The reaction between the carboxyl groups of the components is schematized in Scheme 2 below.

[반응식 1][Reaction Scheme 1]

Figure pat00024
Figure pat00024

[반응식 2][Reaction Scheme 2]

Figure pat00025
Figure pat00025

상기 반응식 1 및 2에서 보는 것과 같이, 모발, 두피, 피부, 손발톱, 가죽 및/또는 섬유와 결합된 아미노산은 샴푸나 세제, 비누 등으로 인한 일반적인 세척 시에도 쉽게 떨어져 나오지 않아 거의 영구적으로 모발, 두피, 피부, 손발톱, 가죽 및/또는 섬유에 부착된 구조를 유지할 수 있다.As can be seen from the above Schemes 1 and 2, the amino acids combined with hair, scalp, skin, nails, leather and / or fibers do not easily come off during general washing due to shampoo, detergent, soap, , The skin, the nails, the leather and / or the structure attached to the fibers.

본 발명에 따른 윤기 강화용 조성물은 상기 기능성 성분 및 반응매개물질 외에 부수적으로 윤기 강화 효과를 증대시킬 수 있는 성분을 추가로 포함할 수 있다. 예를 들어, 팔미트산(palmitic acid), 스테아린산(stearic acid), 라우린산(lauric acid), 미리스트산(myristic acid) 등의 지방산, 지방알콜, 직쇄와 분기쇄의 장쇄 알킬 4급 암모늄염 등의 양이온화 계면활성제, 양이온화 셀룰로오스, 양이온화 구아, 양이온화 폴리비닐피롤리돈 등의 양이온화 폴리머, 실리콘 등과 혼용하면 제제화가 용이해 질 수 있다. 또한, 화장품 제제로의 제형화를 위하여 용제, 계면활성제, 증점제, 안정화제, 방부제, 착색제, pH 조절제, 금속이온 봉쇄제, 착색제, 펄화제, 외관개선제, 안료, 분체입자 등의 화장품 제제화를 위한 성분들을 부수적으로 포함할 수 있다. 상기 제제화를 위한 성분은 전체 조성물 100 중량부에 대하여 40 내지 99 중량부를 사용할 수 있다.The composition for glaze-reinforcing according to the present invention may further comprise, in addition to the functional component and the reaction medium, an ingredient capable of additionally enhancing the gloss-enhancing effect. Examples thereof include fatty acids such as palmitic acid, stearic acid, lauric acid and myristic acid, fatty alcohols, long-chain alkyl quaternary ammonium salts of straight chain and branched chain Or a cationic polymer such as cationic polyvinylpyrrolidone, silicone, etc., can be easily formulated. [0154] In addition, when the cationic surfactant is used in combination with the cationic surfactant, cationic cellulose, cationic guar, cationic polyvinylpyrrolidone, In order to formulate cosmetics such as solvents, surfactants, thickeners, stabilizers, preservatives, coloring agents, pH adjusters, metal ion sequestering agents, coloring agents, pearlizing agents, external appearance improvers, pigments and powder particles, Components may be incidentally included. The ingredients for the formulation may be used in an amount of 40 to 99 parts by weight based on 100 parts by weight of the total composition.

본 발명에 따른 윤기 강화용 조성물은 관능기를 가지는 윤기 강화 기능성 성분을 포함하여 윤기 강화용 조성물의 처방에 이용될 수 있다. 모발에 있어서, 샴푸-전(pre-shampoo) 제품, 샴푸, 린스 트리트먼트, 왁스, 스프레이, 무스, 헤어 로션, 에센스, 헤어 크림, 팩, 마스크, 시트, 타블랫, 패치, 스트립, 연고타입, 영구 염모제, 일시 염모제, 펌제 등의 모발에 사용할 수 있는 화장품 제제들을 모두 포함할 수 있으며, 피부에 있어서, 스킨, 로션, 에센스, 세럼, 크림, 젤, 파운데이션, 파우더, 메이크업베이스, 포인트 메이크업, 마스크, 패치 등의 피부에 사용할 수 있는 화장품 제제들을 모두 포함할 수 있으며, 섬유에 있어서도, 섬유유연제, 섬유 염색제, 세탁세제, 트리트먼트제, 전후처리제, 세탁보조제, 부분오염 제거제, 스프레이 등의 섬유에 사용할 수 있는 섬유 케어 제제들을 모두 포함할 수 있다. 가죽 제품에 있어서도 크림, 로션, 에센스, 세럼, 젤, 왁스, 스프레이, 세정제, 크리너, 부분오염제거제, 연고타입, 일시염모제, 영구염모제, 광택제, 스트립, 시트 등 가죽 처리용의 모든 제제를 포함할 수 있으며, 이에 한정되는 것은 아니다.The composition for glaze-reinforcing according to the present invention can be used in the formulation of a composition for glaze-strengthening including a gloss-enhancing functional component having a functional group. Hair, lotion, essence, hair cream, pack, mask, sheet, tablet, patch, strip, ointment type, shampoo, shampoo, shampoo, rinse treatment, wax, spray, A lotion, essence, serum, cream, gel, foundation, powder, make-up base, point make-up, mask, The present invention can also be applied to a textile such as a fabric softener, a fiber dye, a laundry detergent, a treatment agent, a post-treatment agent, a laundry auxiliary agent, a partial decontamination agent, a spray, etc. And may include all of the fiber care agents that may be used. Leather products also include all formulations for leather processing such as creams, lotions, essences, serums, gels, waxes, sprays, cleansers, cleaners, partial decontamination agents, ointment types, temporary hair dyes, permanent hair dyes, polishes, But is not limited thereto.

본 발명에 따른 윤기용 조성물에서 기능성 성분의 효과를 증대시키기 위하여 디옥틸 석시네이트, 디옥틸 아디페이트, 디에틸 세바케이트 등과 같은 2-염기산 에스테르유와 폴리올, 폴리에틸렌 글리콜, 프로필렌 글리콜, 헥실렌 글리콜, 부타네디올 및 그들의 이성체, 글리세롤, 벤질 알코올, 에톡시디글리콜 및 그 유도체를 사용할 수 있다. 상기 언급된 용제는 모발 및 피부의 침투성을 증가시키며 난용성 물질의 용제로서 이용된다.In order to increase the effect of the functional ingredient in the composition for shine according to the present invention, it is possible to use a 2-base acid ester oil such as dioctyl succinate, dioctyl adipate, diethyl sebacate and the like, a polyol, polyethylene glycol, propylene glycol, hexylene glycol, Butanediol and their isomers, glycerol, benzyl alcohol, ethoxydiglycol and derivatives thereof. The above-mentioned solvents increase the permeability of hair and skin, and are used as a solvent of a poorly soluble substance.

본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예를 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예에 한정되는 것이 아니라, 서로 다른 다양한 형태로 구현될 것이며, 단지 본 발명의 개시가 완전하도록 하고, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이다.Advantages and features of the present invention, and methods of accomplishing the same, will be apparent from and elucidated with reference to the embodiments described hereinafter in detail. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the concept of the invention to those skilled in the art. To provide a complete description of the category.

실시예Example 1 내지 10 및  1 to 10 and 비교예Comparative Example 1 내지 4 1 to 4

하기 표 1에 나타낸 조성과 함량으로 실시예 1 내지 10 및 비교예 1 내지 4의 모발 윤기 강화용 샴푸 조성물을 제조하였다. 제조된 샴푸 조성물로 모발을 깨끗하게 세척한 후, 타올 드라이를 한 3g 정도의 모발 트레스(tress)를 준비하여 SAMBA(Bossa Nova Index)를 이용하여 각각의 초기 윤기를 측정하고, 제조된 조성물을 0.3g씩을 이용하여 30회 샴푸 후의 윤기 및 SLES(Sodium Lauryl Ether Sulfate) 15% 용액으로 3회 세척하고 건조한 후의 윤기를 측정하여 세정에 의한 윤기 지속 효과를 기기 평가하여 비교하였다. 측정기기: SAMBA Hair System (Bossa Nova Technology, USA).The hair shine enhancing shampoo compositions of Examples 1 to 10 and Comparative Examples 1 to 4 were prepared by the compositions and contents shown in Table 1 below. After washing the hair with the prepared shampoo composition, a hair tress of about 3 g which was dried with a towel was prepared and each initial gloss was measured using SAMBA (Bossa Nova Index), and 0.3 g The shine after shampooing 30 times and the 15% solution of SLES (Sodium Lauryl Ether Sulfate) were washed three times, and the shine after drying was measured to evaluate the shine lasting effect by cleaning. Measurement instrument: SAMBA Hair System (Bossa Nova Technology, USA).

(중량%)(weight%) 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 실시예 5Example 5 실시예 6Example 6 실시예 7Example 7 실시예 8Example 8 실시예 9Example 9 실시예 10Example 10 WaterWater To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 Polyquaternium-10Polyquaternium-10 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 EDTA 4NaEDTA 4Na 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 Sodium Lauryl Ether(2mole) Sulfate(30%)Sodium Lauryl Ether (2 mole) Sulfate (30%) 3535 3535 3535 3535 3535 3535 3535 3535 3535 3535 3535 3535 3535 3535 Cocamidopropyl Betaine(30%)Cocamidopropyl Betaine (30%) 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 incense 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 TriptophanTriptophan 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 0.50.5 HistidineHistidine -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- 0.50.5 0.50.5 PhenylalaninePhenylalanine -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- 0.50.5 0.50.5 TyrosineTyrosine -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 0.50.5 0.50.5 Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blockedBenzene, 1,3-bis (1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked -- -- -- -- 1One 1One 1One 1One -- -- -- -- -- 0.50.5 1,1'- methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked1,1'-methylene-bis- (3-isocyanatocyclohexane) -, homopolymer, polyethylene glycol mono-Me-ether-blocked -- -- -- -- -- -- -- -- 1One 1One 1One 1One 1One 0.50.5 pH 조정제pH adjuster 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 합계Sum 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100

  비교
예 1
compare
Example 1
비교
예 2
compare
Example 2
비교
예 3
compare
Example 3
비교
예 4
compare
Example 4
실시
예 1
practice
Example 1
실시
예 2
practice
Example 2
실시
예 3
practice
Example 3
실시
예 4
practice
Example 4
실시
예 5
practice
Example 5
실시
예 6
practice
Example 6
실시
예 7
practice
Example 7
실시
예 8
practice
Example 8
실시
예 9
practice
Example 9
실시
예 10
practice
Example 10
초기Early 18.618.6 18.518.5 18.618.6 18.318.3 18.518.5 18.418.4 18.618.6 18.518.5 18.418.4 18.618.6 18.518.5 18.518.5 18.318.3 18.618.6 30회 샴푸 후30 times after shampooing 16.716.7 16.316.3 16.716.7 16.616.6 19.219.2 1919 19.319.3 19.619.6 19.419.4 19.819.8 19.819.8 19.619.6 21.321.3 21.521.5 SLES 3회 세정 후SLES After 3 rinses 15.315.3 15.515.5 15.515.5 15.315.3 18.418.4 18.618.6 18.518.5 18.618.6 18.918.9 18.918.9 18.818.8 1919 20.620.6 20.720.7

상기 표 2에서 보는 것과 같이, 실시예 1 내지 10 및 비교예 1 내지 4의 실험 결과, 반응 매개 성분을 포함하지 않고 아미노산 성분만을 포함한 비교예 1 내지 4의 조성물에 비해, 반응 매개 성분인 Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blocked(실시예 1~4, 10) 또는 1,1'- methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked(실시예 5~9)를 포함한 경우에 샴푸 사용 후 윤기 및 세정에 의한 윤기 지속 효과가 매우 우수한 것을 확인하였다.As shown in Table 2, the results of the experiments of Examples 1 to 10 and Comparative Examples 1 to 4 show that, compared with the compositions of Comparative Examples 1 to 4 containing no amino acid components but no reaction medium components, 1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked (Examples 1 to 4, 10) or 1,1'-methylene- bis- (3-isocyanatocyclohexane ), homopolymer, and polyethylene glycol mono-Me-ether-blocked (Examples 5 to 9), it was confirmed that the shine lasting effect by shine and washing was excellent.

실시예Example 11 내지 20 및  11 to 20 and 비교예Comparative Example 5 내지 8 5 to 8

하기 표 3에 나타낸 조성과 함량으로 실시예 11 내지 20 및 비교예 5 내지 8의 윤기 강화용 바디 샴푸 조성물을 제조하였고, 각각의 조성물을 10명씩의 소비자를 대상으로 20일 간 사용하도록 한 후, 피부의 윤기 상태를 사용 전 초기 윤기 상태와 비교하여 5점 척도 (5: 매우 우수, 4: 약간 우수, 3: 차이 없음, 2: 효과 없음, 1: 매우 효과 없음)의 관능으로 평가하여 비교하였다.The shampoo compositions for shine-strengthening of Examples 11 to 20 and Comparative Examples 5 to 8 were prepared by the compositions and contents shown in Table 3 below. Each composition was used for 10 days for ten consumers, The shine condition of the skin was compared with the initial glare condition before use to evaluate the sensory qualities of the 5 point scale (5: very good, 4: slightly excellent, 3: no difference, 2: no effect, 1: .

(중량%)(weight%) 비교예 5Comparative Example 5 비교예 6Comparative Example 6 비교예 7Comparative Example 7 비교예 8Comparative Example 8 실시예 11Example 11 실시예 12Example 12 실시예 13Example 13 실시예 14Example 14 실시예 15Example 15 실시예 16Example 16 실시예 17Example 17 실시예 18Example 18 실시예 19Example 19 WaterWater To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 Polyquaternium-7Polyquaternium-7 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 EDTA 4NaEDTA 4Na 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 Lauric AcidLauric Acid 33 33 33 33 33 33 33 33 33 33 33 33 3535 Myristic acidMyristic acid 44 44 44 44 44 44 44 44 44 44 44 44 1515 Sodium Lauryl Ether(2mole) Sulfate(30%)Sodium Lauryl Ether (2 mole) Sulfate (30%) 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 0.90.9 Cocamidopropyl Betaine(30%)Cocamidopropyl Betaine (30%) 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 1515 0.50.5 incense 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.50.5 TriptophanTriptophan 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 HistidineHistidine -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- 0.50.5 PhenylalaninePhenylalanine -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- 0.50.5 TyrosineTyrosine -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 0.50.5 Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blockedBenzene, 1,3-bis (1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked -- -- -- -- 1One 1One 1One 1One -- -- -- -- -- 1,1'- methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked 1,1'-methylene-bis- (3-isocyanatocyclohexane) -, homopolymer, polyethylene glycol mono-Me-ether-blocked -- -- -- -- -- -- -- -- 1One 1One 1One 1One 1One pH 조정제pH adjuster 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 합계Sum 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100

비교
예 5
compare
Example 5
비교
예 6
compare
Example 6
비교
예 7
compare
Example 7
비교
예 8
compare
Example 8
실시
예 11
practice
Example 11
실시
예 12
practice
Example 12
실시
예 13
practice
Example 13
실시
예 14
practice
Example 14
실시
예 15
practice
Example 15
실시
예 16
practice
Example 16
실시
예 17
practice
Example 17
실시
예 18
practice
Example 18
실시
예 19
practice
Example 19
2.32.3 2.52.5 2.22.2 2.22.2 3.83.8 3.83.8 3.93.9 3.83.8 44 3.93.9 3.93.9 4.14.1 4.44.4

상기 표 4에서 보는 것과 같이, 실시예 11 내지 20 및 비교예 5 내지 8의 실험 결과, 반응 매개 성분을 포함하지 않고 아미노산 성분만을 포함한 비교예 5 내지 8의 조성물에 비해, 반응 매개 성분인 Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blocked(실시예 11~14, 20) 또는 1,1'- methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked(실시예 15~19)를 포함한 경우에 바디 샴푸 사용 후 피부 윤기 개선 효과가 매우 우수한 것을 확인하였다. As shown in Table 4, the results of the experiments of Examples 11 to 20 and Comparative Examples 5 to 8 show that compared with the compositions of Comparative Examples 5 to 8 containing no amino acid components but no reaction medium components, 1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked (Examples 11 to 14, 20) or 1,1'-methylene- bis- (3-isocyanatocyclohexane ) -, homopolymer, and polyethylene glycol mono-Me-ether-blocked (Examples 15 to 19) were included.

실시예Example 21 내지 30 및  21 to 30 and 비교예Comparative Example 9 내지 12 9-12

하기 표 5에 나타낸 조성과 함량으로 실시예 21 내지 30 및 비교예 9 내지 12의 섬유용 액체 세제 조성물을 제조하였다. 제조된 조성물은 길이 20cm, 폭 5cm의 실크 원단을 사용하여 SAMBA(Bossa Nova Index)를 이용하여 각각의 초기 윤기를 측정하고, 제조된 조성물을 0.3g씩을 이용하여 3회 샴푸 및 세탁 후 윤기와 SLES(Sodium Lauryl Ether Sulfate) 15% 용액으로 1회 세척하고 건조한 후의 윤기를 측정하여 세정에 의한 윤기 지속 효과를 기기 평가하여 비교하였다. 측정기기: SAMBA Hair System (Bossa Nova Technology, USA).The liquid detergent compositions for fibers of Examples 21 to 30 and Comparative Examples 9 to 12 were prepared by the compositions and contents shown in Table 5 below. Each of the prepared compositions was measured by SAMBA (Bossa Nova Index) using a silk fabric having a length of 20 cm and a width of 5 cm. After the shampooing and washing after 3 times of shampooing and washing, (Sodium Lauryl Ether Sulfate) 15% solution, and measured the gloss after drying. Measurement instrument: SAMBA Hair System (Bossa Nova Technology, USA).

(중량%)(weight%) 비교예 9Comparative Example 9 비교예 10Comparative Example 10 비교예 11Comparative Example 11 비교예 12Comparative Example 12 실시예 21Example 21 실시예 22Example 22 실시예 23Example 23 실시예 24Example 24 실시예 25Example 25 실시예 26Example 26 실시예 27Example 27 실시예 28Example 28 실시예 29Example 29 실시예 30Example 30 WaterWater To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 Lauryl SulfateLauryl Sulfate 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 Laurylalcohol Ethoxylate(12mole)Laurylalcohol Ethoxylate (12 moles) 77 77 77 77 77 77 77 77 77 77 77 77 77 77 Lauric AcidLauric Acid 44 44 44 44 44 44 44 44 44 44 44 44 44 44 SodiumtriphosphateSodiumtriphosphate 1010 1010 1010 1010 1010 1010 1010 1010 1010 1010 1010 1010 1010 1010 incense 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 0.90.9 TriptophanTriptophan 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 0.50.5 HistidineHistidine -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- 0.50.5 0.50.5 PhenylalaninePhenylalanine -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 -- 0.50.5 0.50.5 TyrosineTyrosine -- -- -- 0.50.5 -- -- -- 0.50.5 -- -- -- 0.50.5 0.50.5 0.50.5 Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blockedBenzene, 1,3-bis (1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked -- -- -- -- 1One 1One 1One 1One -- -- -- -- -- 0.50.5 1,1'- methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked 1,1'-methylene-bis- (3-isocyanatocyclohexane) -, homopolymer, polyethylene glycol mono-Me-ether-blocked -- -- -- -- -- -- -- -- 1One 1One 1One 1One 1One 0.50.5 pH 조정제pH adjuster 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 적량Suitable amount 합계Sum 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100 100100

  비교
예 9
compare
Example 9
비교
예 10
compare
Example 10
비교
예 11
compare
Example 11
비교
예 12
compare
Example 12
실시
예 21
practice
Example 21
실시
예 22
practice
Example 22
실시
예 23
practice
Example 23
실시
예 24
practice
Example 24
실시
예 25
practice
Example 25
실시
예 26
practice
Example 26
실시
예 27
practice
Example 27
실시
예 28
practice
Example 28
실시
예 29
practice
Example 29
실시
예 30
practice
Yes 30
초기Early 4.54.5 4.54.5 4.64.6 4.54.5 4.44.4 4.54.5 4.54.5 4.54.5 4.64.6 4.64.6 4.44.4 4.54.5 4.54.5 4.64.6 3회 세탁 후After 3 washing 1.61.6 1.51.5 1.61.6 1.71.7 3.53.5 3.63.6 3.63.6 3.73.7 3.53.5 3.73.7 3.83.8 3.43.4 4.44.4 4.54.5 SLES 1회 세정 후After SLES 1 rinse 1.31.3 1.11.1 1.31.3 1.31.3 3.23.2 3.33.3 3.23.2 3.33.3 3.33.3 3.43.4 3.43.4 3.23.2 3.83.8 3.83.8

상기 표 6의 결과에서 보는 것과 같이, 상기 실시예 21 내지 30 및 비교예 9 내지 12의 실험 결과, 반응 매개 성분을 포함하지 않고 아미노산 성분만을 포함한 비교예 5 내지 8의 조성물에 비해, 반응 매개 성분인 Benzene, 1,3-bis(1-isocyanato-1-methylethyl)-, homopolymer, polyethylene glycol mono-Me-ether-blocked(실시예 11~14, 20) 또는 1,1'-methylene-bis-(3-isocyanatocyclohexane)-, homopolymer, polyethylene glycol mono-Me-ether-blocked(실시예 15~19)를 포함한 경우에 섬유용 세제 사용 후 실크 섬유의 세탁에 의한 윤기 저하 효과가 현저히 개선되었고, SLES 세정에 의한 윤기 지속 효과도 우수함을 확인하였다.As shown in the results of Table 6 above, the results of the experiments of Examples 21 to 30 and Comparative Examples 9 to 12 show that, compared to the compositions of Comparative Examples 5 to 8 containing no amino acid components but no reaction medium components, Benzene, 1,3-bis (1-isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-Me-ether-blocked (Examples 11 to 14, 20) or 1,1'- 3-isocyanatocyclohexane), homopolymer and polyethylene glycol mono-Me-ether-blocked (Examples 15 to 19), the effect of washing the silk fibers after washing with the textile fabric was remarkably improved, And it was confirmed that the effect of lasting gloss was also excellent.

Claims (15)

트립토판(Trp), 히스티딘(His), 타이로신(Tyr), 페닐알라닌(Phe), 아르기닌(Arg), 시스테인(Cys), 메티오닌(Met), 알란토인(Allantoin) 및 이들의 유도체로 이루어진 군에서 선택된 하나 이상의 기능성 성분; 및 반응매개물질을 포함하는 윤기 강화용 조성물.At least one member selected from the group consisting of tryptophan (Trp), histidine (His), tyrosine (Tyr), phenylalanine (Phe), arginine (Arg), cysteine (Cys), methionine Functional ingredients; And a reaction medium. 제 1 항에 있어서,
반응매개물질은 카르보디이미드계 화합물, 디하이드록시퀴놀린계 화합물, 아미늄계 화합물 및 포스포늄계 화합물로 이루어진 군에서 선택된 하나 이상인 윤기 강화용 조성물.
The method according to claim 1,
The reaction medium is at least one selected from the group consisting of a carbodiimide compound, a dihydroxyquinoline compound, an aminium compound, and a phosphonium compound.
제 2 항에 있어서,
카르보디이미드계 화합물은 분자 내에 하나 이상의 N=C=N 구조를 포함하는 화합물인 윤기 강화용 조성물.
3. The method of claim 2,
Wherein the carbodiimide compound is a compound containing at least one N = C = N structure in the molecule.
제 2 항에 있어서,
카르보디이미드계 화합물은 하기 화학식 1로 표시되는 화합물인 윤기 강화용 조성물:
[화학식 1]
Figure pat00026

상기 화학식 1에서, A는
Figure pat00027
,
Figure pat00028
,
Figure pat00029
,
Figure pat00030
,
Figure pat00031
,
Figure pat00032
,
Figure pat00033
,
Figure pat00034
,
Figure pat00035
,
Figure pat00036
,
Figure pat00037
,
Figure pat00038
,
Figure pat00039
,
Figure pat00040
,
Figure pat00041
,
Figure pat00042
,
Figure pat00043
,
Figure pat00044
,
Figure pat00045
,
Figure pat00046
Figure pat00047
로 이루어진 군에서 선택된 하나 이상의 구조를 가지는 것으로, 반복 단위 양 말단에 이소시아네이트기를 갖는 모노머이고, R은 수소; 또는 탄소수 1 내지 500의 직쇄, 분지쇄 또는 고리형의 탄화수소; 또는 벤젠 고리형의 탄화수소;를 나타내며, 상기 탄화수소 분자의 일부에 이중결합을 포함하거나; O, N, S, P 및 Si로 이루어진 군에서 선택된 하나 이상의 화합물이 치환된 형태이거나; 음이온, 양이온, 양쪽성 형태로 치환된 형태이거나; 또는 금속이온이 염 형태로 결합된 구조를 포함하고, m은 1 내지 100의 정수이다.
3. The method of claim 2,
Wherein the carbodiimide compound is a compound represented by the following formula (1): < EMI ID =
[Chemical Formula 1]
Figure pat00026

In the above formula (1), A represents
Figure pat00027
,
Figure pat00028
,
Figure pat00029
,
Figure pat00030
,
Figure pat00031
,
Figure pat00032
,
Figure pat00033
,
Figure pat00034
,
Figure pat00035
,
Figure pat00036
,
Figure pat00037
,
Figure pat00038
,
Figure pat00039
,
Figure pat00040
,
Figure pat00041
,
Figure pat00042
,
Figure pat00043
,
Figure pat00044
,
Figure pat00045
,
Figure pat00046
And
Figure pat00047
, Wherein R is a hydrogen atom or a monovalent hydrocarbon group having one or more structures selected from the group consisting of hydrogen, A straight chain, branched chain or cyclic hydrocarbon having 1 to 500 carbon atoms; Or a benzene ring-type hydrocarbon, and the hydrocarbon molecule includes a double bond in a part of the molecule; At least one compound selected from the group consisting of O, N, S, P, and Si is substituted; Anion, cation, amphoteric form; Or a structure in which metal ions are bonded in the form of a salt, and m is an integer of 1 to 100.
제 2 항에 있어서,
디하이드록시퀴놀린계 화합물은 하기 화학식 2로 표시되는 화합물인 윤기 강화용 조성물:
[화학식 2]
Figure pat00048

상기 화학식 2에서 R1은 수용성 비이온계 고분자; 비드 형태 및 레진 형태의 고분자 수지; 및 실리카 비드로 이루어진 군에서 선택된 하나이고, R2 및 R3는 각각 탄소수 1 내지 10의 직쇄; 또는 분지된 포화 알킬기; 또는 불포화 알킬기일 수 있다.
3. The method of claim 2,
Wherein the dihydroxyquinoline-based compound is a compound represented by the following formula (2): < EMI ID =
(2)
Figure pat00048

Wherein R 1 is a water-soluble nonionic polymer; Polymeric resins in bead and resin form; And silica beads, and R 2 and R 3 are each a straight chain of 1 to 10 carbon atoms; Or branched saturated alkyl groups; Or an unsaturated alkyl group.
제 5 항에 있어서,
수용성 비이온계 고분자는 분자량이 20,000 Da 미만인 폴리에틸렌글라이콜 (PEG), 폴리비닐알콜 (PVA), 폴리에틸렌옥사이드 (PEO), 폴리아크릴로니트릴 (PAN), 폴리비닐피롤리돈 (PVP), 폴리이소프로필아크릴아미드 (PNIPPAm), 셀룰로오스 유도체, 스타치 유도체, 덱스트란 및 구아검으로 이루어진 군에서 선택된 하나 이상의 고분자인 윤기 강화용 조성물.
6. The method of claim 5,
The water-soluble non-ionic polymer may be selected from the group consisting of polyethylene glycol (PEG), polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylonitrile (PAN), polyvinylpyrrolidone Wherein the composition is at least one polymer selected from the group consisting of isopropyl acrylamide (PNIPPAm), cellulose derivatives, starch derivatives, dextran and guar gum.
제 5 항에 있어서,
비드 형태 또는 레진 형태의 고분자 수지는 분자량이 20,000 Da 미만인 스티렌, 에틸렌, 부타디엔, 아크릴로니트릴, 메틸스티렌, 테레프탈레이트, 염화에틸렌, 에테르케톤, 에테르이미드, 에테르설폰, 프탈아미드, 페닐렌에테르, 산화페닐렌, 페닐렌설파이드, 설폰, 우레탄, 비닐리덴플루오라이드 및 테트라플루오르에틸렌으로 이루어진 군에서 선택된 하나 이상의 단량체로 중합된 고분자인 윤기 강화용 조성물.
6. The method of claim 5,
The polymeric resin in bead or resin form can be selected from styrene, ethylene, butadiene, acrylonitrile, methylstyrene, terephthalate, ethylene chloride, ether ketone, etherimide, ether sulfone, phthalamide, phenylene ether, Wherein the polymer is a polymer polymerized with at least one monomer selected from the group consisting of phenylene, phenylene sulfide, sulfone, urethane, vinylidene fluoride and tetrafluoroethylene.
제 5 항에 있어서,
실리카 비드는 직경이 100㎚ 내지 1㎜인 윤기 강화용 조성물.
6. The method of claim 5,
The silica bead has a diameter of 100 nm to 1 mm.
제 2 항에 있어서,
아미늄계 화합물은 N-[(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트 N-옥사이드(N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide), N-[(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로보레이트(N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluoroborate), 2-(3,4-(N-[(1H- 벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트 N-옥사이드(2-(3,4-(N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide), 2-(3,4-디하이드로-4-옥소-1,2,3-벤조트리아진-3-일)-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate), O-(3,4,-디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일)-1,1,3,3-테트라메틸우로늄 헥사플루오로보레이트(O-(3,4,-dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl)-1,1,3,3-tetramethyluronium hexafluoroborate), O-(3,4,-디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일)-1,1,3,3-테트라메틸우로늄 헥사플루오로포스페이트(O-(3,4,-dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), 2-(2-옥소-1(2H)-피리딜-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-(2-oxo-1(2H)-pyridyl-1,1,3,3-tetramethyluronium tetrafluoroborate), 2-(2-옥소-1(2H)-피리딜-1,1,3,3-테트라메틸우로늄 테트라플루오로포스페이트(2-(2-oxo-1(2H)-pyridyl-1,1,3,3-tetramethyluronium tetrafluorophosphate), 2-석시니미도-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-succinimido-1,1,3,3-tetramethyluronium tetrafluoroborate)), 2-석시니미도-1,1,3,3-테트라메틸우로늄 테트라플루오로포스페이트(2-succinimido-1,1,3,3-tetramethyluronium tetrafluorophosphate), N,N,N',N'-비스(테트라메틸렌-O-펜타플루오로페닐우로늄 테트라플루오로보레이트(N,N,N',N'-bis(tetramethylene-O-pentafluorophenyluronium tetrafluoroborate), N,N,N',N'-비스(테트라메틸렌-O-펜타플루오로페닐우로늄 헥사플루오로포스페이트(N,N,N',N'-bis(tetramethylene-O-pentafluorophenyluronium hexafluorophosphate), N-[6-트리플루오로메틸(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N-메틸메트아미늄 테트라플루오로보레이트 N-옥사이드(N-[6-trifluoromethyl(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethaminium tetrafluoroborate N-oxide), N-[6- 트리플루오로메틸(1H-벤조트리아졸-1-일)(디메틸아미노)메틸렌]-N- 메틸메트아미늄 헥사플루오로포스페이트 N-옥사이드(N-[6-trifluoromethyl(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethaminium hexafluorophosphate N-oxide), N-[(디메틸아미노)-1H-1,2,3-트리아졸로[4,5,b]피리딘-1-일]메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트 N-옥사이드(N-[(dimethylamino)-1H-1,2,3-triazolo[4,5,b]pyridin-1-yl]methylene]-N-methylmethanaminium hexafluorophosphate N-oxide), N-[(디메틸아미노)-1H-1,2,3-트리아졸로[4,5-b]피리딘-1-일메틸렌]-N-메틸메탄아미늄 테트라플루오로보레이트 N-옥사이드(N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminium tetrafluoroborate N-oxide), N-[(디메틸아미노)-1H-1,2,3- 트리아졸로[4,5-b]피리딘-1-일메틸렌]-N- 메틸메탄아미늄 헥사플루오로포스페이트 N-설파이드(N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminium hexafluorophosphate N-sulfide), S-(1-옥사이도-1-피리디닐)-1,1,3,3-테트라메틸티우로늄 헥사플루오로포스페이트(S-(1-oxido-1-pyridinyl)-1,1,3,3-tetramethylthiouronium hexafluorophosphate), O-[시아노(에톡시카르보닐)메틸렌아미노]-N,N,N',N'-테트라메틸우로늄 테트라플루오로보레이트(O-[cyano(ethoxycarbonyl)methyleneamino]-N,N,N',N'-tetramethyluronium tetrafluoroborate), O-[시아노(에톡시카르보닐)메틸렌아미노]-N,N,N',N'-테트라메틸티우로늄 헥사플루오로포스페이트(O-[cyano(ethoxycarbonyl)methyleneamino]-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-[(디시아노메틸리덴)-아미노]-1,1,3,3,-테트라메틸티우로늄 헥사플루오로포스페이트(O-[(dicyanomethylidene)-amino]-1,1,3,3,-tetramethyluronium hexafluorophosphate, O-[(디메톡시카르보닐메틸리덴)-아미노]-1,1,3,3,-테트라메틸티우로늄 헥사플루오로포스페이트(O-[(dimethoxycarbonylmethylidene)-amino]-1,1,3,3,-tetramethyluronium hexafluorophosphate), N-[(시아노(피리딘-2-일)메틸렌 아미노옥시) (디메틸아미노)메틸렌]-N-메틸메탄아미늄 헥사플루오로포스페이트(N-[(cyano(pyridin-2-yl)methylene aminooxy)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate), 2-(5-노보넨-2,3-디카르복시미도)-1,1,3,3-테트라메틸티우로늄 테트라플루오로보레이트(2-(5-norbornene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate), 2-프탈이미도-1,1,3,3-테트라메틸우로늄 테트라플루오로보레이트(2-phthalimido-1,1,3,3-tetramethyluronium tetrafluoroborate, 비스(테트라메틸렌)클로로포름아미디늄 헥사플루오로포스페이트(bis(tetramethylene)chloroformamidinium hexafluorophosphate), (1H-벤조트리아졸-1-일)(1-피롤리디닐메틸렌) 피롤리디늄 헥사플루오로포스페이트 N-옥사이드((1H-benzotriazol-1-yl)(1-pyrollidinylmethylene)pyrrolidinium hexafluorophosphate N-oxide), 1-(1-피롤리디닐-1H-1,2,3-트리아졸로[4,5-b]피리딘-1-일메틸렌) 피롤리디늄 헥사플루오로포스페이트 N-옥사이드(1-(1-pyrrolidinyl-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N-oxide), O-(3,4-디하이드로-4-옥소-1,2,3-벤조트리아진-3-일)-1,1,3,3-비스(테트라메틸렌)우라늄 헥사플루오로포스페이트(O-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-1,1,3,3-bis(Tetramethylene)uranium hexafluorophosphate), O-(3,4- 디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일)-1,1,3,3-비스(테트라메틸렌) 우라늄 헥사플루오로포스페이트(O-(3,4-Dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl)-1,1,3,3-bis(Tetramethylene) uranium hexafluorophosphate), N,N,N',N'-비스(테트라메틸렌)-O-펜타플루오로 페닐우로늄 헥사플루오로포스페이트(N,N,N',N'-bis(tetra methylene)-O-pentafluoro phenyluronium hexafluorphosphate), N,N,N',N'-비스(테트라메틸렌)-S-펜타플루오로사이오페닐우로늄 헥사플루오로포스페이트 (N,N,N',N'-bis(tetramethylene)-S-pentafluorothiophenyluronium hexafluorphosphate), 1-(1-피롤리디닐-1H-1,2,3-트리아졸로[4,5-b]피리딘-1-일메틸렌) 피롤리디늄 헥사플루오로포스페이트 N-설파이드(1-(1-pyrrolidinyl-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N-sulfide), N,N,N',N'-비스(테트라메틸렌)-O-2-니트로페닐우로늄 헥사플루오로포스페이트 (N,N,N',N'-bis(tetramethylene)-O-2-nitrophenyluronium hexafluorophosphate), N,N,N',N'-비스(테트라메틸렌)-O-펜타플루오로페닐우로늄 헥사플루오로포스페이트(N,N,N',N'-bis(tetramethylene)-O-pentafluorophenyluronium hexafluorohosphate), O-(벤조트리아졸-1-일)-1,1,3,3-비스(펜타메틸렌) 헥사플루오로포스페이트(O-(benzotriazol-1-yl)-1,1,3,3-bis(pentamethylene) hexafluorophosphate), O-(7-아자벤조트리아졸-1-일)-1,1,3,3-비스(펜타메틸렌)-우로늄 헥사플루오로포스페이트(O-(7-azabenzotriazol-1-yl)-1,1,3,3-bis(pentamethylene)-uronium hexafluorophosphate), 2-[2-옥소-1(2H)-피리딜]-1,1,3,3-비스(펜타메틸렌) 우로늄 테트라플루오로보레이트(2-[2-oxo-1(2H)-pyridyl]-1,1,3,3-bis(pentamethylene) uronium tetrafluoroborate), 2-클로로-1,3-디메틸이미다졸리디늄 헥사플루오로포스페이트(2-chloro-1,3-dimethylimidazolidinium hexafluorophosphate), O-(벤조트리아졸-1-일)-1,3-디메틸-1,3-디메틸렌 우로늄 헥사플루오로포스페이트(O-(benzotriazol-1-yl)-1,3-dimethyl-1,3-dimethylene uronium hexafluorophosphate), O-(7-아자벤조트리아졸-1-일)-1,3-디메틸-1,3-디메틸엔우로늄 헥사플루오로포스페이트(O-(7-azabenzotriazol-1-yl)-1,3-dimethyl-1,3-dimethyleneuronium hexafluorophosphate), 2-클로로-1,3-디메틸피리미디늄 헥사플루오로포스페이트(2-chloro-1,3-dimethylpyrimidinium hexafluorophosphate), O-(벤조트리아졸-1-일)-1,3-디메틸-1,3-트리메틸렌우로늄 헥사플루오로포스페이트(O-(benzotriazol-1-yl)-1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), O-(7- 아자벤조트리아졸-1-일)-1,3-디메틸-1,3-트리메틸렌우로늄 헥사플루오로포스페이트(O-(7-azabenzotriazol-1-yl)-1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), (7-벤조트리아졸-일)-1,1,3-트리메틸-1-헥사플루오로포스페이트((7-benzotriazol-yl)-1,1,3-tri methyl-1-hexafluorophosphate), (7-아자벤조트리아졸-일)-1,1,3- 트리메틸-1-페닐우로늄 헥사플루오로포스페이트((7-azabenzotriazol-yl)-1,1,3-trimethyl-1-phenyluronium hexafluorophosphate), O-(1H-벤조트리아졸-1-일)-1,1-디메틸-3,3-테트라메틸렌 우로늄 헥사플루오로포스페이트(O-(1H-benzotriazol-1-yl)-1,1-dimethyl-3,3-tetramethylene uronium hexafluorophosphate), O-(1H-1,2,3-트리아졸로[4,5-b]피리딘-일)-1,1-디메틸-3,3-테트라메틸렌우로늄 헥사플루오로포스페이트(O-(1H-1,2,3-triazolo[4,5-b]pyridin-yl)-1,1-dimethyl-3,3-tetramethyleneuronium hexafluorophosphate), O-(1H-벤조트리아졸-1-일)-1,1-디메틸-3,3-펜타메틸렌 우로늄 헥사플루오로포스페이트(O-(1H-benzotriazol-1-yl)-1,1-dimethyl-3,3-pentamethylene uronium hexafluorophosphate), 6-클로로-1((디메틸아미노)(모르폴리노)메틸렌)-1H-벤조 트리아졸리움 헥사플루오로포스페이트-3 옥사이드(6-chloro-1((dimethylamino)(morpholino)methylene)-1H-benzo triazolium hexafluorophosphate-3 oxide), 3-((디메틸아미노)-(모르폴리노)메틸렌)-1H-[1,2,3]트리아졸로[4,5-b]피리디늄 헥사플루오로포스페이트(3-((dimethylamino)-(morpholino)methylene)-1H-[1,2,3]triazolo[4,5-b]pyridinium hexafluorophosphate), 6-트리플루오로메틸-1-((디메틸아미노)-(모르폴리노)메틸렌)-1H-벤조트리아졸리움 헥사플루오로포스페이트-3-옥사이드(6-trifluoromethyl-1-((dimethylamino)-(morpholino)methylene)-1H-benzotriazolium hexafluorophsphate-3-oxide), 1-((디메틸아미노)-(모르폴리노)) 옥시펜타플루오로페닐메텐이미늄 헥사플루오로포스페이트(1-((dimethylamino)-(morpholino)) oxypentafluorophenylmetheniminium hexafluorophosphate), 1-[(1-(시아노-2-에톡시-2-옥소에틸리덴아미노옥시)-디메틸아미노 모르폴리노메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1-(cyano-2-ethoxy-2-oxoethylideneaminooxy)-dimethylamino morpholinomethylene)] methanaminium hexafluorophosphate), 1-[(1-(디시아노메틸렌아미노옥시) 디메틸아미노 모르폴리노메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1-(dicyanomethyleneaminooxy) dimethylamino morpholinomethylene)] methanaminium hexafluorophosphate), 1-[(1,3-디에톡시-1,3-디옥소프로판-2-일리덴아미노옥시) 디메틸아미노 모르폴리노메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1,3-diethoxy-1,3-dioxopropan-2-ylideneaminooxy) dimethylaminomorpholinomethylene)] methanaminium hexafluorophosphate), N-[(시아노(피리딘-2-일)메틸렌아미노옥시) (디메틸아미노)메틸렌]-N-모르폴리노메탄아미늄 헥사플루오로포스페이트(N-[(cyano(pyridin-2-yl)methyleneaminooxy) (dimethylamino)methylene]-N-morpholinomethanaminium hexafluorophosphate), 1-[(1-(시아노-2-에톡시-2-옥소에틸리덴아미노옥시)디메틸아미노피롤로디노 메틸렌)] 메탄아미늄 헥사플루오로포스페이트(1-[(1-(cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylaminopyrrolodino methylene)]methanaminium hexafluorophosphate), 1-((디시아노메틸렌아미노옥시) 모르폴리노메틸렌)피롤리디늄 헥사플루오로포스페이트(1-((dicyanomethyleneaminooxy) morpholinomethylene)pyrrolidinium hexafluorophosphate), 1-[(1,3-디에톡시-1,3-디옥소프로판-2-일덴아미노옥시)-디메틸아미노-피롤로디노메틸렌]] 메탄아미늄 헥사플루오로포스페이트(1-[(1,3-diethoxy-1,3-dioxopropan-2-yldeneaminooxy)-dimethylamino-pyrrolodinomethylene]] methanaminium hexafluorophosphate), 1-[(1-(시아노-2-에톡시-2-옥소에틸리덴 아미노옥시)-디메틸아미노-피롤로디노메틸렌)]메탄아미늄 헥사플루오로포스페이트(1-[(1-(cyano-2-ethoxy-2-oxoethylidene aminooxy)-dimethylamino-pyrrolodinomethylene)]methanaminium hexafluororphosphate), 1-((1-시아노-2-에톡시-2-옥소에틸리덴아미노옥시)(모르폴리노)메틸렌)피롤리디늄 헥사플루오로포스페이트(1-((1-cyano-2-ethoxy-2-oxoethylideneaminooxy)(morpholino)methylene)pyrrolidinium hexafluorophospahte), 벤조트리아졸-1-일옥시-N,N-디메틸-메탄아미늄 헥사클로로안티모네이트(benzotriazol-1-yloxy-N,N-dimethyl-methanaminium hexachloroantimonate), 5-(1H-벤조트리아졸-1-일옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(1H-benzotriazol-1-yloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate), 5-(7-아자벤조트리아졸-1-일옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(7-azabenzotriazol-1-yloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate), 1-(1H-벤조트리아졸-1-일옥시)페닐-메틸렌 피롤리디늄 헥사클로로안티모네이트(1-(1H-benzotriazol-1-yloxy)phenyl-methylene pyrrolidinium hexachloroantimonate), 5-(펜타플루오로페닐옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(pentafluorophenyloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonite), 5-(석시니미딜옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(succinimidyloxy)-3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate), 5-(3',4'-디하이드로-4'-옥소-1',2',3'-벤조트리아진-3'-일옥시)-3,4-디하이드로-1-메틸-2H-피롤리움 헥사클로로안티모네이트(5-(3',4'-dihydro-4'-oxo-1',2',3'-benzotriazin-3'-yloxy)-3,4-diydro-1-methyl-2H-pyrrolium hexachloroantimonate) 및 이의 유도체로 이루어진 군에서 선택된 하나 이상인 윤기 강화용 조성물.
3. The method of claim 2,
The aminium-based compound can be prepared by reacting N - [(1H-benzotriazol-1-yl) (dimethylamino) methylene] -N- methylmethanaminium hexafluorophosphate N- (dimethylamino) methylene] -N-methylmethanaminium hexafluorophosphate N-oxide, N - [(1H-benzotriazol- [(1H-benzotriazol-1-yl) (dimethylamino) methylene] -N-methylmethanaminium hexafluoroborate, 2- (3,4- N-methylmethanaminium hexafluorophosphate (N-oxide), N-methylmethanaminium hexafluorophosphate (N-oxide), N- 2- (3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate (2- 4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate), O- (3,4 dihydro- - Azaben Triazin-3-yl) -1,1,3,3-tetramethyluronium hexafluoroborate (O- (3,4-dihydro-4-oxo- 1,2,3-triazin-3-yl) -1,1,3,3-tetramethyluronium hexafluoroborate), O- (3,4 dihydro-4-oxo-5-azabenzo-1,2,3 3-yl) -1,1,3,3-tetramethyluronium hexafluorophosphate (O- (3,4-dihydro-4-oxo-5-azabenzo- triazin-3-yl) -1,1,3,3-tetramethyluronium hexafluorophosphate), 2- (2-oxo-1 (2H) -pyridyl-1,1,3,3-tetramethyluronium tetrafluoroborate (2H) -pyridyl-1,1,3,3-tetramethyluronium tetrafluoroborate, 2- (2-oxo-1 Tetramethyluronium tetrafluorophosphate, 2- (2-oxo-1 (2H) -pyridyl-1,1,3,3-tetramethyluronium tetrafluorophosphate) 2-succinimido-1,1,3,3-tetramethyluronium tetrafluoroborate), 2-succinimido-1,1,3,3-tetramethyluronium tetrafluorophosphate N, N ', N'-bis (tetramethylene-O-pentafluorophenyluronium tetrafluoroborate (N, N, N, N'-bis (tetramethylene-O-pentafluorophenyluronium tetrafluoroborate), N, N, N ' , N'-bis (tetramethylene-O-pentafluorophenyluronium hexafluorophosphate), N- [6-trifluoromethyl (1H-benzotriazol- 1-yl) (dimethylamino) methylene] -N- methylmethaminium tetrafluoro A method for preparing a compound of formula (I) wherein the compound is a compound selected from the group consisting of N- [6-trifluoromethyl (1H-benzotriazol-1-yl) (dimethylamino) methylene] -N-methylmethaminium tetrafluoroborate N-oxide, 1-yl) (dimethylamino) methylene] -N-methylmethaminium (N-methylmethylammonium) hexafluorophosphate hexafluorophosphate N-oxide), N - [( (Dimethylamino) -1H-1,2,3-triazolo [4,5, b] pyridin-1-yl] methylene] -N- methylmethanaminium hexafluorophosphate N- -1H-1,2,3-triazolo [4,5, b] pyridin-1-yl] methylene] -N-methylmethanaminium hexafluorophosphate N-oxide), N - [(dimethylamino) -Triazolo [4,5-b] pyridin-1-ylmethylene] -N-methylmethanaminium tetrafluoroborate N-oxide (N - [(dimethylamino) -1H-1,2,3-triazolo [ , 5-b] pyridin-1-ylmethylene] -N-methylmethanaminium tetrafluoroborate N-oxide), N - [(dimethylamino) -1H-1,2,3- triazolo [4,5- b] pyridin- Ylmethylene] -N-methylmethanaminium hexafluorophosphate N-sulfide (N - [(dimethylamino) -1H-1,2,3-triazolo [4,5- b] pyridin- methylmethanaminium hexafluorophosphate N-sulfide, S- (1-oxido-1-pyridinyl) -1,1,3,3-tetramethylthiuramonium hexafluorophosphate (S- -1,1,3,3-tetramethylthiouronium hexafluorophosphate), O- [ N, N ', N', N'-tetramethyluronium tetrafluoroborate (O- [cyano (ethoxycarbonyl) methyleneamino] -tetramethyluronium tetrafluoroborate, O- [cyano (ethoxycarbonyl) methyleneamino] -N, N, N ', N'-tetramethylthiuramonium hexafluorophosphate N, N, N ', N'-tetramethyluronium hexafluorophosphate, O - [(dicyanomethylidene) - amino] -1,1,3,3, - tetramethylthionium hexafluorophosphate ) -amino] -1,1,3,3, -tetramethyluronium hexafluorophosphate, O - [(dimethoxycarbonylmethylidene) -amino] -1,1,3,3, - tetramethylthiuronium hexafluorophosphate (O - [(dimethoxycarbonylmethylidene) -amino] -1,1,3,3, -tetramethyluronium hexafluorophosphate, N - [(cyano (pyridin- 2- yl) methyleneaminooxy) Methylmethanaminium hexafluorophosphate (N - [(cyano (pyridin-2- methyleneaminooxy) methylene] -N-methylmethanaminium hexafluorophosphate), 2- (5-norbornene-2,3-dicarboximido) -1,1,3,3-tetramethylthiuronium tetrafluoro (5-norbornene-2,3-dicarboximido) -1,1,3,3-tetramethyluronium tetrafluoroborate), 2- phthalimido-1,1,3,3-tetramethyluronium tetrafluoroborate (2-phthalimido-1,1,3,3-tetramethyluronium tetrafluoroborate, bis (tetramethylene) chloroformamidinium hexafluorophosphate), (1H-benzotriazol- 1-pyrrolidinylmethylene) pyrrolidinium hexafluorophosphate N-oxide), 1- (1-pyrrolidinyl-1H-benzotriazol- 1,2,3-triazolo [4,5-b] pyridin-1-ylmethylene) pyrrolidinium hexafluorophosphate N-oxide (1- 4,5-b] pyridin-1-ylmethylene ) pyrrolidinium hexafluorophosphate N-oxide, O- (3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-bis (tetramethylene) (3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl) -1,1,3,3-bis (tetramethylene) uranium hexafluorophosphate), O- (3,4-dihydro-4-oxo-5-azabenzo-1,2,3-triazine-3-yl) -1,1,3,3-bis (tetramethylene) uranium hexafluorophosphate (3,4-Dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl) -1,1,3,3-bis (tetramethylene) uranium hexafluorophosphate) N ', N'-bis (tetramethylene) -O-pentafluorophenyluronium hexafluorophosphate (N, N', N'- N, N ', N'-bis (tetramethylene) -S-pentafluorothiophenyluronium hexafluorophosphate), 1, - (1-pyrrolidinyl-1H-1,2,3-triazolo [4,5-b] -1-ylmethylene) pyrrolidinium hexafluorophosphate N- (1-pyrrolidinyl-1H-1,2,3-triazolo [4,5-b] pyridin- N, N ', N'-bis (tetramethylene) -O-2-nitrophenyluronium hexafluorophosphate (N, -nitrophenyluronium hexafluorophosphate, N, N, N ', N'-bis (tetramethylene) -O-pentafluorophenyluronium hexafluorophosphate, pentafluorophenyluronium hexafluorohosphate, O- (benzotriazol-1-yl) -1,1,3,3-bis (pentamethylene) hexafluorophosphate , 3-bis (pentamethylene) hexafluorophosphate, O- (7-azabenzotriazol-1-yl) -1,1,3,3-bis (pentamethylene) -ouronium hexafluorophosphate 2-oxo-1 (2H) -pyridyl] -1,1,3,3-bis (pentamethylene) (Pentamethylene) uranium tetra Fluoroborate (2- [2-oxo-1 (2H) -pyridyl] -1,1,3,3-bis (pentamethylene) uronium tetrafluoroborate), 2-chloro-1,3-dimethylimidazolidinium hexafluor (2-chloro-1,3-dimethylimidazolidinium hexafluorophosphate), O- (benzotriazol-1-yl) -1,3-dimethyl-1,3-dimethylenuronium hexafluorophosphate -1-yl) -1,3-dimethyl-1,3-dimethylene uronium hexafluorophosphate, O- (7-azabenzotriazol-1-yl) -1,3-dimethyl- 1-yl-1,3-dimethyl-1,3-dimethyleneuronium hexafluorophosphate), 2-chloro-1,3-dimethylpyrimidinium hexafluorophosphate (2- 1,3-dimethylpyrimidinium hexafluorophosphate, O- (benzotriazol-1-yl) -1,3-dimethyl-1,3-trimethylen uronium hexafluorophosphate, -1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), O- (7-azabenzotriazol-1-yl) -1,3-dimethyl- (7-azabenzotriazol-1-yl) -1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate), (7-benzotriazol- 3-trimethyl-1-hexafluorophosphate, (7-azabenzotriazol-yl) -1,1,3- (7-azabenzotriazol-yl) -1,1,3-trimethyl-1-phenyluronium hexafluorophosphate), O- (1H-benzotriazol- 1-dimethyl-3,3-tetramethylene uronium hexafluorophosphate (O- (1H-benzotriazol-1-yl) , 2,3-triazolo [4,5-b] pyridin-yl) -1,1-dimethyl-3,3-tetramethylene uronium hexafluorophosphate (O- (1H-1,2,3-triazolo [4,5-b] pyridin-yl) -1,1-dimethyl-3,3-tetramethyleneuronium hexafluorophosphate), O- (1H-benzotriazol- Pentamethylene uronium hexafluorophosphate Benzotriazol-1-yl) -1,1-dimethyl-3,3-pentamethylene uronium hexafluorophosphate), 6-chloro-1 ((dimethylamino) (morpholino) methylene) 3 - ((dimethylamino) - (morpholino) methylene) -1H-benzo triazolium hexafluorophosphate-3 oxide, -1H- [1,2,3] triazolo [4,5-b] pyridinium hexafluorophosphate (3 - ((dimethylamino) - (morpholino) methylene) -1H- [1,2,3] triazolo [ 4,5-b] pyridinium hexafluorophosphate, 6-trifluoromethyl-1 - ((dimethylamino) - (morpholino) methylene) -1H-benzotriazolium hexafluorophosphate- 1 - ((dimethylamino) - (morpholino) methylene) -1H-benzotriazolium hexafluorophosphate-3-oxide), 1 - ((dimethylamino) - (morpholino)) oxypentafluorophenylmetheniminium hexafluorophosphate (1 - ((dimethylamino) - (morpholino)) oxypentafluor (1 - [(1-cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylaminomorpholinomethylene)] methanaminium hexafluorophosphate - (cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylamino morpholinomethylene)] methanaminium hexafluorophosphate), 1 - [(1- (dicyanomethyleneaminooxy) dimethylaminomorpholinomethylene)] methanaminium hexafluorophosphate 1 - [(1-dicyanomethyleneaminooxy) dimethylamino morpholinomethylene]] methanaminium hexafluorophosphate), 1 - [(1,3-diethoxy-1,3-dioxopropane-2-ylideneaminooxy) dimethylamino morpholinomethylene) 2-ylideneaminooxy)] methanaminium hexafluorophosphate), N - [(cyano (pyridin-2-yl) methylene) Aminooxy) (dimethylamino) methylene] -N-morpholinomethanaminium hexafluoro (1-cyano-2-ethoxy-2-oxoethylidene) methyleneamino] methylene] -N-morpholinomethanaminium hexafluorophosphate), 1 - [ 2-ethoxy-2-oxoethylideneaminooxy) dimethylaminopyrrolodino methylene]] methanaminium hexafluorophosphate), 1 - ((dicyano (Dicyanomethyleneaminooxy) morpholinomethylene) pyrrolidinium hexafluorophosphate), 1 - [(1,3-diethoxy-1,3-dioxopropane-2- (1 - [(1,3-diethoxy-1,3-dioxopropan-2-yldeneaminooxy) -dimethylamino-pyrrolodinomethylene]] methanaminium hexafluorophosphate ), 1 - [(1- (cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylamino-pyrrolodi (1-cyano-2-ethoxy-2-oxoethylideneaminooxy) -dimethylamino-pyrrolodinomethylene)] methanaminium hexafluorophosphate), 1 - 2-ethoxy-2-oxoethylideneaminooxy) (morpholino) methylene) pyrrolidinium (1-cyano-2- hexafluorophosphate, benzotriazol-1-yloxy-N, N-dimethyl-methanaminium hexachloroantimonate, 5- (1H-benzotriazole- 1-yloxy) -3,4-dihydro-1-methyl-2H-pyrrole hexachloroantimonate (5- (1H-benzotriazol- -2H-pyrrolium hexachloroantimonate), 5- (7-azabenzotriazol-1-yloxy) -3,4-dihydro-1-methyl-2H-pyrrole hexachloroantimonate -1-yloxy) -3,4-dihydro-1-methyl-2H-pyrrole hexachloroantimon ate and 1- (1H-benzotriazol-1-yloxy) phenyl-methylenepyrrolidinium hexachloroantimonate (1- (1H-benzotriazol-1-yloxy) phenyl-methylene pyrrolidinium hexachloroantimonate) (Pentafluorophenyloxy) -3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonite), 5- (succinimidyloxy) -3,4-dihydro-1-methyl-2H-pyrrolium hexachloroantimonate (5- (succinimidyloxy) -3,4-dihydro- ), 5- (3 ', 4'-dihydro-4'-oxo-1', 2 ', 3'- benzotriazin-3'-yloxy) -3,4- dihydro- 2H-pyrrole hexachloroantimonate (5- (3 ', 4'-dihydro-4'-oxo-1', 2'3'-benzotriazin-3'-yloxy) -3,4- -methyl-2H-pyrrolium hexachloroantimonate) and derivatives thereof.
제 2 항에 있어서,
포스포늄계 화합물은 분자 내에 하나 이상의 포스포늄염(Phosphonium salts) 구조를 포함하는 화합물인 윤기 강화용 조성물.
3. The method of claim 2,
The phosphonium-based compound is a compound containing at least one phosphonium salts structure in the molecule.
제 2 항에 있어서,
포스포늄계 화합물은 벤조트리아졸-1-일옥시트리스(디메틸아미노) 포스포늄 헥사플루오로포스페이트(benzotriazol-1-yloxytris(dimethylamino) phosphonium hexafluorophosphate), 브로모트리스 (디메틸아미노)포스포늄 헥사플루오로포스페이트(bromotris (dimethylamino)phosphonium hexafluorophosphate), 클로로트리 (피롤리디노) 포스포늄 헥사플루오로포스페이트 (chlorotri (pyrrolidino) phosphonium hexafluorophosphate), 브로모트리 (피롤리디노) 포스포늄 헥사플루오로포스페이트(bromotri (pyrrolidino) phosphonium hexafluorophosphate), 클로로트리스 (디메틸아미노) 포스포늄 헥사플루오로포스페이트(chloro-tris (dimethylamino) phosphonium hexafluorophosphate), 벤조트리아졸-1-일옥시트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트(benzotriazol-1-yloxytris (pyrrolidino) phosphonium hexafluorophosphate), [(7-아자벤조트리아졸-1-일)옥시]트리스-(디메틸아미노) 포스포늄 헥사플루오로포스페이트([(7-azabenzotriazol-1-yl)oxy]tris-(dimethylamino) phosphonium hexafluorophosphate), [(7-아자벤조트리아졸-1-일)옥시]트리스-(피롤리디노) 포스포늄 헥사플루오로포스페이트([(7-azabenzotriazol-1-yl)oxy]tris-(pyrrolidino) phosphonium hexaflurophosphate), O-[(시아노-(에톡시카르보닐)메틸리덴)-아미노]-일옥시트리스피롤리디노 포스포늄 헥사플루오로포스페이트(O-[(cyano-(ethoxycarbonyl)methyliden)-amino]- yloxytripyrrolidino phosphonium hexafluorophosphate), [(6-니트로벤조트리아졸―일)옥시]트리스-(피롤리디노) 포스포늄 헥사플루오로포스페이트([(6-nitrobenzotriazol―yl)oxy]tris-(pyrrolidino) phosphonium hexafluorophosphate), [(6-트리플루오로메틸)벤조트리아졸-1-일]-옥시 트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트([[(6-trifluoromethyl)benzotriazol-1-yl]oxy-tris(pyrrolidino)phosphonium hexafluorophosphate), [4-니트로-6-(트리플루오로메틸) 벤조트리아졸-1-일]옥시] 트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트([4-nitro-6-(trifluoromethyl)benzotriazol-1-yl]oxy] tris(pyrrolidino) phosphonium hexafluorophosphate), (6-클로로-벤조트리아졸-1-일옥시) 트리스 (피롤리디노) 포스포늄 헥사플루오로포스페이트((6-chloro-benzotriazol-1-yloxy)tris (pyrrolidino)-phosphonium hexafluorophosphate), N',N',N',N'-비스(테르라메틸렌)-O-펜타플루오로 페닐우로늄 헥사플루오로포스페이트(N',N',N',N'-bis(tetramethylene)-O-pentafluoro phenyluronium hexafluorophosphate), (피리딜-2-티오)트리스 (피롤리디노) 포스포늄 헥사플루오로포스페이트((pyridyl-2-thio)tris (pyrrolidino)-phosphonium hexafluorophosphate), [(3,4-디하이드로-4-옥소-1,2,3-벤조트리아진-3-일)옥시]트리스(피롤리디노) 포스포늄 헥사플루오로포스페이트([(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)oxy]tris-(pyrrolidino)phosphonium hexafluorophosphate), [(3,4-디하이드로-4-옥소-5-아자벤조-1,2,3-트리아진-3-일] 트리스 (피롤리디노) 포스포늄 헥사플루오로포스페이트([(3,4-dihydro-4-oxo-5-azabenzo-1,2,3-triazin-3-yl] tris-(pyrrolidino) phosphonium hexafluorophosphate) 및 이의 유도체로 이루어진 군에서 선택된 하나 이상인 윤기 강화용 조성물.
3. The method of claim 2,
The phosphonium compounds include benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphate, bromotris (dimethylamino) phosphonium hexafluorophosphate (dimethylamino) phosphonium hexafluorophosphate, (bromotris (dimethylamino) phosphonium hexafluorophosphate), chlorotri (pyrrolidino) phosphonium hexafluorophosphate, bromotri (pyrrolidino) phosphonium hexafluorophosphate, phosphonium hexafluorophosphate, chloro-tris (dimethylamino) phosphonium hexafluorophosphate, benzotriazol-1-yloxytris (pyrrolidino) phosphonium hexafluorophosphate, 1-yloxytris (pyrrolidino) phosphonium hexafluorophosphate), [(7-azabenzotriazol-1-yl) oxy [(7-azabenzotriazol-1-yl) oxy] tris- (dimethylamino) phosphonium hexafluorophosphate), [(7-azabenzotriazol- [(7-azabenzotriazol-1-yl) oxy] tris- (pyrrolidino) phosphonium hexaflurophosphate), O - [(cyano- (ethoxycarbonyl) methylidene ) - amino] -yloxytrispyrrolidinophosphonium hexafluorophosphate (O - [(cyano- (ethoxycarbonyl) methyliden) -amino] -yloxytripyrrolidino phosphonium hexafluorophosphate), [(6-nitrobenzotriazol- (6-nitrobenzotriazol-yl) oxy] tris- (pyrrolidino) phosphonium hexafluorophosphate), [(6-trifluoromethyl) benzotriazol- ] - oxytris (pyrrolidino) phosphonium hexafluorophosphate ([[(6-trifluoromethyl) benzotriazol-1-yl] oxy- ino phosphonium hexafluorophosphate, [4-nitro-6- (trifluoromethyl) benzotriazol-1-yl] oxy] tris (pyrrolidino) phosphonium hexafluorophosphate, (6-chloro- benzothiazol-1-yloxy) tris (pyrrolidino) phosphonium hexafluorophosphate, benzotriazol-1-yloxy) tris (pyrrolidino) -phosphonium hexafluorophosphate), N ', N', N ', N'-bis (terrhymethylene )- O-pentafluorophenyluronium hexafluorophosphate (Pyridyl-2-thio) tris (pyrrolidino) phosphonium hexafluorophosphate, N, (pyrrolidino) -phosphonium hexafluorophosphate), [(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3- yl) oxy] tris (pyrrolidino) phosphonium hexafluorophosphate [(3,4-d 4-oxo-1,2,3-benzotriazin-3-yl) oxy] tris- (pyrrolidino) phosphonium hexafluorophosphate), [ 3-yl] tris (pyrrolidino) phosphonium hexafluorophosphate ([(3,4-dihydro-4-oxo-5-azabenzo-1,2,3-triazin- ] tris- (pyrrolidino) phosphonium hexafluorophosphate) and derivatives thereof.
제 1 항에 있어서,
상기 조성물은 모발, 두피, 피부, 손발톱, 가죽 또는 섬유에 윤기를 부여하는 것인 윤기 강화용 조성물.
The method according to claim 1,
Wherein the composition imparts radiance to hair, scalp, skin, nail, leather or fiber.
제 1 항에 있어서,
기능성 성분은 전체 조성물 100 중량부에 대하여 0.000001 내지 30 중량부를 포함하는 윤기 강화용 조성물.
The method according to claim 1,
Wherein the functional component comprises 0.000001 to 30 parts by weight based on 100 parts by weight of the total composition.
제 1 항에 있어서,
반응매개물질은 전체 조성물 100 중량부에 대하여 0.001 내지 20 중량부를 포함하는 윤기 강화용 조성물.
The method according to claim 1,
Wherein the reaction medium material comprises 0.001 to 20 parts by weight based on 100 parts by weight of the total composition.
제1항의 윤기 강화용 조성물을 포함하는 케어 제품.
A care product comprising the gloss enhancing composition of claim 1.
KR1020170050248A 2017-04-19 2017-04-19 Composition for improving of shining effect KR102349949B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170050248A KR102349949B1 (en) 2017-04-19 2017-04-19 Composition for improving of shining effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170050248A KR102349949B1 (en) 2017-04-19 2017-04-19 Composition for improving of shining effect

Publications (2)

Publication Number Publication Date
KR20180117307A true KR20180117307A (en) 2018-10-29
KR102349949B1 KR102349949B1 (en) 2022-01-11

Family

ID=64101459

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170050248A KR102349949B1 (en) 2017-04-19 2017-04-19 Composition for improving of shining effect

Country Status (1)

Country Link
KR (1) KR102349949B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130122070A (en) 2012-04-30 2013-11-07 (주)아모레퍼시픽 Hair cosmetic composition containing extract of camellia japonica l. seed
KR20140141303A (en) 2013-05-31 2014-12-10 (주)아모레퍼시픽 Hair cleansing composition containing high content of oil
KR101663055B1 (en) * 2015-08-27 2016-10-06 주식회사 엘지생활건강 Composition for skin surface modification

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130122070A (en) 2012-04-30 2013-11-07 (주)아모레퍼시픽 Hair cosmetic composition containing extract of camellia japonica l. seed
KR20140141303A (en) 2013-05-31 2014-12-10 (주)아모레퍼시픽 Hair cleansing composition containing high content of oil
KR101663055B1 (en) * 2015-08-27 2016-10-06 주식회사 엘지생활건강 Composition for skin surface modification

Also Published As

Publication number Publication date
KR102349949B1 (en) 2022-01-11

Similar Documents

Publication Publication Date Title
KR101787310B1 (en) Keratin treatment formulations and methods
KR101869807B1 (en) Non-petrochemically derived cationic emulsifiers that are neutralized amino acid esters and related compositions and methods
JP2018012731A (en) Composition containing carbodiimide-based compound
KR102043855B1 (en) Functional composition for surface modification
KR20100129262A (en) Keratin derivatives and methods of making the same
KR100929956B1 (en) Now Hair Conditioning Compositions With Persistence
KR102006952B1 (en) Cosmetics compositions for prevention and improvement of wrinkle
CN106572955B (en) Non-petrochemical derived cationic emulsifiers and related compositions and methods
KR20160079802A (en) Peptide composition and respective uses
WO2017122615A1 (en) Cosmetic
CN111194205A (en) Contains naringin: personal care compositions of zinc complexes and methods of use thereof
KR20170099656A (en) Cosmetic compositions for moisturizing
US11975091B2 (en) Composition for enhancing protein strength
CA2643784A1 (en) Personal care compositions comprising ionic liquids
KR102349949B1 (en) Composition for improving of shining effect
KR100376538B1 (en) Hair shampoo composition reinforcing a fibroid material of interior of hair
KR20090090138A (en) Functionalized branched chain lipid derivatives binding proteins on skin or hair, and personal care product containing the same
WO2018131798A1 (en) Composition for enhancing protein strength
Alexander Hair cosmetics and cosmeceuticals
JP2009107977A (en) Cosmetic
KR102327526B1 (en) Functional composition for surface modification
KR101945404B1 (en) A hair composition comprising peptides
CN109789071B (en) Hair care composition
KR20180003870A (en) Cosmetic compositions for moisturizing
KR20180131162A (en) Functional composition for surface modification

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant